B03XA01|Erythropoietin/Epoetin beta/|BH049|NEORECORMON|solution for injection, pre-filled syringe|10000|IU|6|60000|Roche Registration GmbH, |502.78|2|1|0|C|8|5||0|0.00838|1981|0|
B03XA01|Erythropoietine /human recombinant|BH050|Binocrit|SOL. INJ. PRE-FILLED SYRINGE|10000 IU|IU|6|60000|Sandoz GmbH, |502.78|2|1|0|C|8|5||0|0.00838|2991|0|
B03XA01|Erythropoietine /human recombinant|BH056|Retacrit|SOL. INJ. PRE-FILLED SYRINGE|10000 IU|IU|6|60000|Pfizer Europe MA EEIG, |502.78|2|1|0|C|8|5||0|0.00838|2992|0|
B03XA02|DARBEPOETIN ALFA|BH057|Aranesp|SOLUTION FOR INJECTION PREFILLED SYRINGE WITH NEEDLE GUARD|300 mcg/0,6 ml|mcg|1|300|Amgen Europe B.V., |661.37|3|1|0|C|8|5||0|2.20334|3462|0|
B03XA02|DARBEPOETIN ALFA|BH058|Aranesp|SOLUTION FOR INJECTION PREFILLED SYRINGE WITH NEEDLE GUARD|150 mcg/0,3 ml|mcg|1|150|Amgen Europe B.V., |330.63|3|1|0|C|8|5||0|2.20334|3461|0|
B03XA03|METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA|BH081|MIRCERA|SOL. INJ. PRE-FILLED SYRINGE|150 mcg/0,3 ml|mcg|1|150|Roche Registration GmbH, |372|3|1|0|C||5||0|2.47821|2721|0|
B02BB01|HUMAN FIBRINOGEN|BH087|Haemocomplettan P|POWD.FOR SOL. FOR INJ/INF|1 000 mg|mg|1|1000|CSL Behring GmbH, |828.17||||H|||||0.82771|3502||
B02BD01|COAGULATION FACTOR IX, II, VII AND X IN COMB.|BH088|OCTAPLEX|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Octapharma (IP) SPRL, |338.74||||H|||||0.67747|3417||
B02BD01|COAGULATION FACTOR IX, II, VII AND X IN COMB.|BH089|Prothromplex Total NF|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|600IU|IU|1|600|Baxalta Innovations GmbH, |406.49||||H|||||0.67747|2753||
B02BD02|COAGULATION FACTOR VIII|BH090|Beriate|POWD. AND SOLV. FOR SOL. FOR INJECTION/INFUSION|1000IU|IU|1|1000|CSL Behring GmbH, |603.24||||H|||||0.60324|4047||
B02BD02|COAGULATION FACTOR VIII|BH091|Beriate|POWD. AND SOLV. FOR SOL. FOR INJECTION/INFUSION|250IU|IU|1|250|CSL Behring GmbH, |150.81||||H|||||0.60324|4045||
B02BD02|COAGULATION FACTOR VIII|BH092|Beriate|POWD. AND SOLV. FOR SOL. FOR INJECTION/INFUSION|500IU|IU|1|500|CSL Behring GmbH, |301.62||||H|||||0.60324|4046||
B02BD02|COAGULATION FACTOR VIII|BH093|Fanhdi|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Instituto Grifols S.A., |301.62||||H|||||0.60324|903||
B02BD02|COAGULATION FACTOR VIII|BH094|Fanhdi|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|250IU|IU|1|250|Instituto Grifols S.A., |150.81||||H|||||0.60324|902||
B02BD02|COAGULATION FACTOR VIII|BH095|Fanhdi|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|1000IU|IU|1|1000|Instituto Grifols S.A., |603.24||||H|||||0.60324|904||
B02BD02|COAGULATION FACTOR VIII|BH096|Immunate|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Baxalta Innovations GmbH, |301.62||||H|||||0.60324|2441||
B02BD02|COAGULATION FACTOR VIII|BH097|OCTANATE|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Octapharma (IP) SPRL, |301.62||||H|||||0.60324|773||
B02BD02|COAGULATION FACTOR VIII|BH098|OCTANATE|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|1000IU|IU|1|1000|Octapharma (IP) SPRL, |603.24||||H|||||0.60324|3650||
B02BD02|COAGULATION FACTOR VIII|BH099|Advate|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Takeda Manufacturing Austria AG, |515.35||||H|||||1.03019|4000||
B02BD02|COAGULATION FACTOR VIII|BH104|NovoEight|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Novo Nordisk A.S., |515.35||||H|||||1.03019|4038||
B02BD02|COAGULATION FACTOR VIII|BH105|Nuwiq|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Octapharma AB, |515.35||||H|||||1.03019|4082||
B02BD02|COAGULATION FACTOR VIII|BH106|ReFacto AF|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Pfizer Europe MA EEIG, |515.35||||H|||||1.03019|3640||
B02BD02|COAGULATION FACTOR VIII|BH108|Adynovi|POWDER AND SOLVENT FOR INJECTION|500IU|IU|1|500|Baxalta Innovations GmbH, |588.75||||H|||||1.17748|16387||
B02BD02|COAGULATION FACTOR VIII|BH110|Elocta|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|1000IU|IU|1|1000|Swedish Orphan Biovitrum AB, |1177.5||||H|||||1.17748|15668||
B02BD02|COAGULATION FACTOR VIII|BH111|Elocta|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|250IU|IU|1|250|Swedish Orphan Biovitrum AB, |294.38||||H|||||1.17748|15666||
B02BD02|COAGULATION FACTOR VIII|BH112|Elocta|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Swedish Orphan Biovitrum AB, |588.75||||H|||||1.17748|15667||
B02BD02|COAGULATION FACTOR VIII|BH113|Elocta|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|3000 IU|IU|1|3000|Swedish Orphan Biovitrum AB, |3532.5||||H|||||1.17748|16051||
B02BD02|COAGULATION FACTOR VIII|BH114|Elocta|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|2000 IU|IU|1|2000|Swedish Orphan Biovitrum AB, |2355||||H|||||1.17748|16050||
B02BD02|COAGULATION FACTOR VIII|BH115|Elocta|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|1500 IU|IU|1|1500|Swedish Orphan Biovitrum AB, |1766.25||||H|||||1.17748|16049||
B02BD03|FACTOR VIII INHIBITOR BYPASSING ACTIVITY|BH116|Feiba|POWDER AND SOLVENT FOR SOLUTION FOR INFUSION|25 U/ml (500 U)|IU|1|500|Baxalta Innovations GmbH, |725.51||||H|||||1.45102|15828||
B02BD04|COAGULATION FACTOR IX|BH118|Aimafix|POWDER AND SOLVENT FOR SOLUTION FOR INFUSION|500IU|IU|1|500|Kedrion S.p.A., |383.6||||H|||||0.7672|369||
B02BD04|COAGULATION FACTOR IX|BH119|IMMUNINE|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION/INFUSION|600IU|IU|1|600|Baxalta Innovations GmbH, |460.32||||H|||||0.7672|2442||
B02BD04|COAGULATION FACTOR IX|BH120|OCTANINE F|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Octapharma (IP) SPRL, |383.6||||H|||||0.7672|765||
B02BD04|COAGULATION FACTOR IX|BH121|Alprolix|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|1000IU|IU|1|1000|Swedish Orphan Biovitrum AB, |2014.91||||H|||||2.02168|15906||
B02BD04|COAGULATION FACTOR IX|BH122|Alprolix|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|3000 IU|IU|1|3000|Swedish Orphan Biovitrum AB, |6044.74||||H|||||2.02168|15908||
B02BD04|COAGULATION FACTOR IX|BH123|Alprolix|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|2000 IU|IU|1|2000|Swedish Orphan Biovitrum AB, |4029.82||||H|||||2.02168|15907||
B02BD04|COAGULATION FACTOR IX|BH124|Alprolix|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Swedish Orphan Biovitrum AB, |1007.46||||H|||||2.02168|15905||
B02BD04|COAGULATION FACTOR IX|BH125|Alprolix|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|250IU|IU|1|250|Swedish Orphan Biovitrum AB, |503.73||||H|||||2.02168|15904||
B02BD04|COAGULATION FACTOR IX|BH126|BeneFIX|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Pfizer Europe MA EEIG, |478.21||||H|||||0.95642|1849||
B02BD06|VON WILLEBRAND FACTOR AND COAG FACTORVIII IN COMB|BH127|Wilate 500|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Octapharma (IP) SPRL, |475.49||||H|||||0.94343|3418||
B02BD08|EPTACOG ALFA (ACTIVATED)|BH128|NovoSeven|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|2 mg (100 KIU)|MG|1|2|Novo Nordisk A.S., |2062.85||||H|||||1031.424|15557||
B02BD08|EPTACOG ALFA (ACTIVATED)|BH129|NovoSeven|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|5 mg (250 KIU)|MG|1|5|Novo Nordisk A.S., |5157.13||||H|||||1031.424|15558||
B02BD02|COAGULATION FACTOR VIII|BH130|Jivi|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Bayer AG, |588.75||||H|||||1.17748|16728||
B02BD02|COAGULATION FACTOR VIII|BH131|Jivi|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|1000 IU|IU|1|1000|Bayer AG, |1177.5||||H|||||1.17748|16729||
B02BD04|COAGULATION FACTOR IX|BH132|Refixia|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Novo Nordisk A/S, |1007.46||||H|||||2.02168|17127||
B02BD02|COAGULATION FACTOR VIII|BH133|Esperoct|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Novo Nordisk A/S, |588.75||||H|||||1.17748|17167||
B02BB01|HUMAN FIBRINOGEN|BH135|Fibryga|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION/INFUSION|1000 mg|mg|1|1000|Octapharma (IP) SPRL, |828.17||||H|||||0.82771|17263||
B02BD02|COAGULATION FACTOR VIII|BH136|Afstyla|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|1000 IU|IU|1|1000|CSL Behring GmbH, |1030.7||||H|||||1.03019|17416||
B02BD02|COAGULATION FACTOR VIII|BH137|Afstyla|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|250IU|IU|1|250|CSL Behring GmbH, |257.68||||H|||||1.03019|17415||
B02BD02|COAGULATION FACTOR VIII|BH138|Afstyla|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|CSL Behring GmbH, |515.35||||H|||||1.03019|17414||
B03XA06|Luspatercept|BH139|Reblozyl|POWDER FOR SOLUTION FOR INJECTION|25 mg|mg|1|25|Bristol-Myers Squibb Pharma EEIG, |2505.03|1|2|0|C|6|0||1|100.11575|53266|1|
B03XA06|Luspatercept|BH140|Reblozyl|POWDER FOR SOLUTION FOR INJECTION|75 mg|mg|1|75|Bristol-Myers Squibb Pharma EEIG, |7511.76|1|2|0|C|6|0||1|100.11575|53267|1|
B02BD02|COAGULATION FACTOR VIII|BH142|Kovaltry|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Bayer AG, |515.35||||H|||||1.03019|50209||
B02BD02|COAGULATION FACTOR VIII|BH143|Kovaltry|POWDER AND SOLVENT FOR SOLUTION FOR INFUSION|1000 IU|IU|1|1000|Bayer AG, |1030.7||||H|||||1.03019|50210||
B02BD01|COAGULATION FACTOR IX, II, VII AND X IN COMB.|BH144|Prothromplex Total|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500 IU|IU|1|500|Baxalta Innovations GmbH, |338.74||||H|||||0.67747|62483||
H02AB02|Dexamethasone|HH005|Dexamethasone Sopharma|SOLUTION FOR INJECTION|4 mg/ml - 1 ml|mg|10|40| , |7.85|1|0|0|C|2|7||0|0.19619|42|1|
H02AB02|Dexamethasone|HH006|Dexamethasone KRKA|SOLUTION FOR INJECTION|4 mg/ml - 1 ml|mg|25|100|KRKA d.d., |19.63|1|0|0|C|2|7||0|0.19619|1195|1|
H01CB02|OCTREOTIDE|HH007|Sandostatin LAR|POWD.AND SOLVENT FOR SUSP. INJ.|20 mg|mg|1|20|Novartis Europharm Ltd., |371.44|2|1|0|C|7|2||0|19.12477|2230|1|
H01CB02|OCTREOTIDE|HH008|Sandostatin LAR|POWD.AND SOLVENT FOR SUSP. INJ.|30 mg|mg|1|30|Novartis Europharm Ltd., |557.23|2|1|0|C|7|2||0|19.12477|3243|1|
H02AB02|Dexamethasone|HH018|Dexason|SOL.FOR INJ|4 mg/ml - 1 ml|mg|25|100|Galenika International Kft., |19.63|1|0|0|C|2|7||0|0.19619|17512|1|
J06BA02|IMMUNOGLOBULIN HUMAN NORMAL, INTRAVASCULAR|JH012|IMMUNOVENIN-INTACT 5% IgG|SOL. FOR INF.|50 mg/ml -5 ml|mg|10|2500| - , |359.98|1|4|0|C|1|||1|0.14396|1318|0|
L01DB03|EPIRUBICIN|LH004|Farmorubicin PFS|SOL.FOR INJ|50 mg|mg|1|50|Pfizer Europe MA EEIG, |43.33|1|4|0|C||1||1|0.86617|2322|1|
L01BC01|CYTARABINE|LH005|Alexan|SOL.FOR INJ|50 mg/ml - 20 ml|mg|1|1000|Ebewe Pharma GmbH. N.fg. KG, |29.41|1|4|0|C||1||1|0.0294|866|1|
L01DB03|EPIRUBICIN|LH015|EPIRUBICIN EBEWE|CONCENTRATE FOR SOL. FOR INJECTION/INFUSION|2 mg/ml - 25 ml|mg|1|50|Ebewe Pharma GmbH. N.fg. KG, |43.33|1|4|0|C||1||1|0.86617|3280|1|
L01DB03|EPIRUBICIN|LH024|EPISINDAN|SOL. FOR INF.|2 mg/ml - 50 ml|mg|1|100|  , |86.66|1|4|0|C||1||1|0.86617|1221|1|
L01CD01|PACLITAXEL|LH030|Paclitaxel "Ebewe"|CONCENTRATE FOR SOLUTION FOR INFUSION|6 mg/ml - 16.7 ml|mg|1|100.2|Ebewe Pharma GmbH. N.fg. KG, |28.19|1|4|0|C||1||1|0.21976|1831|1|
L01CD01|PACLITAXEL|LH046|Paclitaxel Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|6 mg/ml - 50 ml|mg|1|300|Accord Healthcare Polska , |84.57|1|4|0|C||1||1|0.21976|2868|1|
L01DB06|Idarubicin|LH047|ZAVEDOS|powder for sol. for inf.|5 mg|mg|1|5|Pfizer Enterprises S.A.R.L., |53.88|1|4|0|C||1||1|10.69048|3287|1|
L01DB06|Idarubicin|LH065|ZAVEDOS|powder for sol. for inf.|10 mg|mg|1|10|Pfizer Enterprises S.A.R.L., |107.76|1|4|0|C||1||1|10.69048|3288|1|
L01DB07|Mitoxantrone|LH075|MITOXANTRON EBEWE|concentrate for solution for infusion|2 mg/ml - 10 ml|mg|1|20|Ebewe Pharma GmbH. N.fg. KG, |68.62|1|4|0|C|7|1||1|3.4296|2338|1|
L01CA04|VINORELBINE|LH078|Vinorelbin Ebewe|CONCENTRATE FOR SOLUTION FOR INFUSION|10 mg/ml - 5 ml|mg|1|50|Ebewe Pharma GmbH. N.fg. KG, |98.7|1|4|0|C|8|1||1|1.9728|3561|1|
L01XA01|CISPLATIN|LH109|Cisplatin Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|1 mg/ml - 50 ml|mg|1|50|Accord Healthcare Polska , |19.48|1|4|0|C||1||1||3729|1|
L01XA02|Carboplatin|LH113|CARBOPLATIN EBEWE|Concentrate for solution for infusion|10 mg/ml-15 ml|mg|1|150|Ebewe Pharma GmbH. N.fg. KG, |58.58|1|4|0|C||1||1|0.3904|868|1|
L03AA02|FILGRASTIM|LH123|Nivestim|SOL. FOR INJ/INF IN PRE-FILLED SYRINGE|30 MIU/0.5 ml|mcg|5|1500|Pfizer Europe MA EEIG, |108.13|3|1|0|C|7|5||0|0.072|2918|0|
L03AA02|FILGRASTIM|LH128|Zarzio|SOL. FOR INJ/INF IN PRE-FILLED SYRINGE|30 MIU/0.5 ml|mcg|5|1500|Sandoz GmbH, |108.13|3|1|0|C|7|5||0|0.072|2598|0|
L01EH01|LAPATINIB|LH137|Tyverb|FILM-COATED TABLET|250 mg|mg|140|35000|Novartis Europharm Ltd., |2402.28|4|0|0|C|3|3||0|0.06862|3392|1|
L01EA03|NILOTINIB|LH139|Tasigna|CAPSULE, HARD|200 mg|mg|28|5600|Novartis Europharm Ltd., |598.4|4|0|0|C|3|3||0|0.1068|1828|1|
L01EA03|NILOTINIB|LH140|Tasigna|CAPSULE, HARD|150 mg|mg|28|4200|Novartis Europharm Ltd., |448.96|4|0|0|C|3|3||0|0.1068|1827|1|
L01EG01|TEMSIROLIMUS|LH158|Torisel|CONCENTRATE AND SOLVENT FOR SOLUTION FOR INJ.|30 mg|mg|1|30|Pfizer Europe MA EEIG, |1370.44|1|4|0|C||3||1|45.66564|3375|1|
L01FE01|CETUXIMAB|LH160|ERBITUX|SOLUTION FOR INFUSION|5 mg/ml - 20 ml|mg|1|100|Merck Europe B.V., |343.09|1|4|0|C|7|3||1|3.42996|3513|1|
L01FG01|BEVACIZUMAB|LH161|Avastin|CONCENTRATE FOR SOLUTION FOR INFUSION|100 mg|mg|1|100|Roche Registration GmbH, |156.33|1|4|0|C|8|3||1|2.34747|3221|1|
L01FG01|BEVACIZUMAB|LH163|Avastin|CONCENTRATE FOR SOLUTION FOR INFUSION|400 mg|mg|1|400|Roche Registration GmbH, |614.54|1|4|0|C|8|3||1|2.34747|3222|1|
L01FE02|PANITUMUMAB|LH165|Vectibix|CONCENTRATE FOR SOLUTION FOR INFUSION|100 mg|mg|1|100|Amgen Eurpe B.V., |651.28|1|4|0|C|8|3||1|6.5128|3297|1|
L01EX01|SUNITINIB|LH172|Sutent|CAPSULE, HARD|12,5 mg|mg|30|375|Pfizer Europe MA EEIG, |293.32|4|0|0|C|3|3||0|0.78|3307|1|
L01CE01|TOPOTECAN|LH175|Hycamtin|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|4 mg|mg|1|4|Sandoz Pharmaceuticals d.d., |100.08|1|4|0|C||1||1|25.01439|2389|1|
L01EX01|SUNITINIB|LH176|Sutent|CAPSULE, HARD|25 mg|mg|30|750|Pfizer Europe MA EEIG, |586.64|4|0|0|C|3|3||0|0.78|3308|1|
L01EX01|SUNITINIB|LH177|Sutent|CAPSULE, HARD|50 mg|mg|30|1500|Pfizer Europe MA EEIG, |1173.28|4|0|0|C|3|3||0|0.78|3309|1|
L01CE01|TOPOTECAN|LH184|Hycamtin|CAPSULE, HARD|1 mg|mg|10|10|Sandoz Pharmaceuticals d.d., |538.15|4|0|0|C|3|1||0|53.815|3314|1|
L01BA01|METHOTREXATE|LH187|Methotrexate Ebewe|CONCENTRATE FOR SOLUTION FOR INFUSION|100 mg/ml - 10 ml|mg|1|1000|Ebewe Pharma GmbH. N.fg. KG, |32.99|1|4|0|C||1||1|0.03292|2714|1|
L01XX23|MITOTANE|LH202|Lysodren|TABL|500 mg|mg|100|50000|HRA Pharma Rare Disease|1164.86|4|0|0|C|3|1||0|0.0233|3202|1|
L03AX16|PLERIXAFOR|LH218|Mozobil|SOL.FOR INJ|20 mg/ml - 1.2 ml|mg|1|24|Sanofi B.V., |5171.05|3|1|0|C||5||0|215.16|2678|1|
L01BB05|FLUDARABINE|LH219|Fludarabine Actavis|POWD.FOR SOL. FOR INJ/INF|50 mg|mg|1|50|  , |64.56|1|4|0|C||1||1|1.2888|1114|1|
L01XA03|OXALIPLATIN|LH227|Oxaliplatin-Tchaikapharma|POWDER FOR SOLUTION FOR INFUSION|100 mg|mg|1|100| -   , |29.86|1|3|0|C||1||1|0.30432|1419|1|
L01CD02|DOCETAXEL|LH230|Docetaxel Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|80 mg/ 4 ml|mg|1|80|Accord Healthcare S.L.U., |32.95|1|2|0|C||1||1|0.41535|3890|1|
L01CE01|TOPOTECAN|LH233|Topotecan Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|1mg/ml - 4 ml|mg|1|4|Accord Healthcare Polska , |100.08|1|4|0|C||1||1|25.01439|2867|1|
L03AA13|PEGFILGRASTIM|LH234|Neulasta|SOLUTION FOR INJECTION|6 mg|mg|1|6|Amgen Europe B.V., |560.62|3|1|0|C|7|5||0|93.38995|3475|0|
L01XA03|OXALIPLATIN|LH237|OXALIPLATIN ACCORD|CONCENTRATE FOR SOLUTION FOR INFUSION|5 mg/ml - 20 ml|mg|1|100|Accord Healthcare Polska , |29.86|1|3|0|C||1||1|0.30432|1487|1|
L04AD01|CICLOSPORIN|LH243|SANDIMMUN NEORAL|CAPS. SOFT|25 mg|mg|50|1250|Novartis Europharm Ltd., |30.16|4|0|0|C|3|||0|0.02412|1561|0|
L04AD01|CICLOSPORIN|LH244|SANDIMMUN NEORAL|CAPS. SOFT|50 mg|mg|50|2500|Novartis Europharm Ltd., |60.31|4|0|0|C|3|||0|0.02412|3535|0|
L04AD01|CICLOSPORIN|LH253|SANDIMMUN NEORAL|ORAL SOLUTION|5000mg|mg|1|5000|Novartis Europharm Ltd., |136.69|4|0|0|C|3|||0|0.02734|3937|0|
L01BC05|GEMCITABINE|LH260|GEMCITABINE ACCORD|CONCENTRATE FOR SOLUTION FOR INFUSION|100 mg/ml - 10 ml|mg|1|1000|Accord Healthcare Polska , |35.92|1|4|0|C|8|1||1|0.03588|2428|1|
L01CD04|CABAZITAXEL|LH274|Jevtana|CONCENTRATE FOR SOLUTION FOR INFUSION|60 mg|mg|1|60|Sanofi Winthrop Industrie, |1414.99|1|2|0|C|7|1||1|23.57121|3727|1|
L01DB01|DOXORUBICIN|LH275|Doxorubicin Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|2 mg/ml - 25 ml|mg|1|50|Accord Healthcare Polska , |16.67|1|3|0|C|7|1||1|0.33339|1325|1|
L01DB01|DOXORUBICIN|LH281|Myocet liposomal|POWDER, DISPERSION AND CONCENTRATE FOR DISPERSION FOR INFUSION|50 mg|mg|2|100|Cheplapharm Arzneimittel GmbH|1125.91|1|2|0|C|7|1||1|11.25658|3463|1|
L01BC01|CYTARABINE|LH288|Cytarabine Accord|SOL. FOR INJ/INF|100 mg/ml - 10 ml|mg|1|1000|Accord Healthcare Polska , |29.28|1|4|0|C||1||1|0.02928|3910|1|
L01BC06|CAPECITABINE|LH291|Capecitabine Accord|TABL. FILM. COAT.|500 mg|mg|120|60000|Accord Healthcare S.L.U., |112.01|4|0|0|C|3|1||0|0.00187|2314|1|
L01FX04|IPILIMUMAB|LH304|Yervoy|CONCENTRATE FOR SOLUTION FOR INFUSION|5 mg/ml - 10 ml|mg|1|50|Bristol-Myers Squibb Pharma EEIG, |6344.74|1|4|0|C||4||1|126.86637|2253|1|
L01EC01|VEMURAFENIB|LH305|ZELBORAF|TABL. FILM. COAT.|240 mg|mg|56|13440|Roche Registration GmbH, |2502.77|4|0|0|C|3|3||0|0.18622|3683|1|
L01XX41|ERIBULIN|LH306|Halaven|SOL.FOR INJ|0.44mg/ml - 1 vial x 2ml|mg|1|0.88|Eisai GmbH, |257.46|1|4|0|C||1||1|292.37613|2995|1|
L01FD01|TRASTUZUMAB|LH310|Herceptin|SOL.FOR INJ|600 mg/5 ml|mg|1|600|Roche Registration GmbH, |2062.67|3|1|0|C|8|3||0|3.43701|3379|1|
L01CD01|PACLITAXEL|LH317|Paclitaxel Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|6 mg/ml - 16.7 ml|mg|1|100.2|Accord Healthcare Polska , |28.19|1|4|0|C||1||1|0.21976|3067|1|
L01FA01|RITUXIMAB|LH320|MabThera|SOL.FOR INJ|1400mg/15ml|mg|1|1400|Roche Registration GmbH, |2931.7|3|1|0|C||3||0|2.09406|3835|1|
L01XX35|ANAGRELIDE|LH321|THROMBOREDUCTIN|CAPSULE, HARD|0.5 mg|mg|100|50|AOP Orphan Pharmaceuticals GmbH, |228.71|4|0|0|C|3|||0|4.5742|808|1|
L01DB03|EPIRUBICIN|LH332|Episindan|SOLUTION FOR INFUSION|2 mg/ml - 25 ml|mg|1|50|  , |43.33|1|4|0|C||1||1|0.86617|3281|1|
L01FX05|BRENTUXIMAB VEDOTIN|LH334|ADCETRIS|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|50 mg|mg|1|50|Takeda Pharma A/S, |5850.41|1|3|0|C||3||1|118.63464|3425|1|
L01FD02|PERTUZUMAB|LH335|PERJETA|CONCENTRATE FOR SOLUTION FOR INFUSION|420 MG|mg|1|420|Roche Registration GmbH, |4473.1|1|2|0|C|8|3||0|10.64785|4002|1|
L01EB03|AFATINIB|LH336|GIOTRIF|FILM-COATED TABLET|30 mg|mg|28|840|Boehringer Ingelheim International GmbH, |2393.82|4|0|0|C|3|3||0|2.91461|3174|1|
L01EB03|AFATINIB|LH337|GIOTRIF|FILM-COATED TABLET|40 mg|mg|28|1120|Boehringer Ingelheim International GmbH, |3191.76|4|0|0|C|3|3||0|2.91461|3175|1|
L01ED01|CRIZOTINIB|LH338|XALKORI|CAPSULE, HARD|250 mg|mg|60|15000|Pfizer Europe MA EEIG, |8009.29|4|0|0|C|3|3||0|0.53383|3273|1|
L01EK01|AXITINIB|LH339|Inlyta|FILM-COATED TABLET|5 mg|mg|56|280|Pfizer Europe MA EEIG, |2376.31|4|0|0|C|3|3||0|19.14743|3263|1|
L01EJ01|RUXOLITINIB|LH340|JAKAVI|TABL|5 mg|mg|56|280|Novartis Europharm Ltd., |2973.44|4|0|0|C|3|3||0|10.68|3415|1|
L01XX44|AFLIBERCEPT|LH341|ZALTRAP|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 8ml|mg|1|200|Sanofi Winthrop Industrie, |1136.4|1|3|0|C|8|3||1|5.68007|3319|1|
L01XX44|AFLIBERCEPT|LH342|ZALTRAP|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 4ml|mg|1|100|Sanofi Winthrop Industrie, |568.2|1|3|0|C|8|3||1|5.68007|3320|1|
L03AA14|LIPEGFILGRASTIM|LH344|LONQUEX|SOL. INJ. PRE-FILLED SYRINGE|6mg/0.6ml|mg|1|6|Teva B.V, |932.47|3|1|0|C|7|5||0|155.36382|2930|0|
L01AA09|BENDAMUSTINE HYDROCHLORIDE|LH348|Bendamustine Actavis|POWDER FOR CONCENTRATE SOLUTION FOR INFUSION|100 mg|mg|1|100|Teva B.V, |77.5|1|4|0|C|6|1||1|0.81458|4013|1|
L01XG01|BORTEZOMIB|LH349|Vortemyel|POWDER FOR SOLUTION FOR INJECTION|3.5 mg|mg|1|3.5|Zentiva k.s.,  |150|1|4|0|C||3||1|42.84754|4014|1|
L01XG01|BORTEZOMIB|LH354|Bortezomib Actavis|POWD.INJ|3.5 mg|mg|1|3.5|Teva B.V, |150|1|4|0|C||3||1|42.84754|4075|1|
L01FD03|TRASTUZUMAB EMTANSINE|LH358|Kadcyla|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|100 mg/5 ml|mg|1|100|Roche Registration GmbH, |3080.46|1|2|0|C||3||1|30.7977|4095|1|
L01FD03|TRASTUZUMAB EMTANSINE|LH359|Kadcyla|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|160 mg/ 8 ml|mg|1|160|Roche Registration GmbH, |4928.74|1|2|0|C||3||1|30.7977|4096|1|
L01EX04|VANDETANIB|LH360|Caprelsa|FILM-COATED TABLET|100 mg|mg|30|3000|Sanofi B.V., |2295.78|4|0|0|C|3|3||0|0.77336|4051|1|
L01EX04|VANDETANIB|LH361|Caprelsa|FILM-COATED TABLET|300 mg|mg|30|9000|Sanofi B.V., |6887.36|4|0|0|C|3|3||0|0.77336|4052|1|
L01EA04|BOSUTINIB|LH362|Bosulif|FILM-COATED TABLET|100 mg|mg|28|2800|Pfizer Europe MA EEIG, |465.37|4|0|0|C|3|3||0|0.1662|4036|1|
L01EA04|BOSUTINIB|LH363|Bosulif|FILM-COATED TABLET|500 mg|mg|28|14000|Pfizer Europe MA EEIG, |2326.85|4|0|0|C|3|3||0|0.1662|4037|1|
L01EC02|DABRAFENIB|LH364|Tafinlar|CAPSULE, HARD|75 mg|mg|120|9000|Novartis Europharm Ltd., |9914.42|4|0|0|C|3|3||0|1.1191|3563|1|
L01XJ01|VISMODEGIB|LH365|Erivedge|CAPSULE, HARD|150 mg|mg|28|4200|Roche Registration GmbH, |7505.56|4|0|0|C|3|3||0|1.85205|4035|1|
L01AA02|CHLORAMBUCIL|LH366|Leukeran|TABL. FILM. COAT.|2 mg|mg|25|50|Aspen Pharma Trading Ltd., |24.83|4|0|0|C|3|1||0|0.4966|4160|1|
L01BB02|MERCAPTOPURINE|LH368|Puri-Nethol|TABL|50 mg|mg|25|1250|Aspen Pharma Trading Ltd., |20.72|4|0|0|C|3|1||0|0.01658|4159|1|
L01FG02|RAMUCIRUMAB|LH370|Cyramza|CONCENTRATE FOR SOLUTION FOR INFUSION|10 MG/ML - 10 ML|mg|2|200|Eli Lilly Nederland B.V., |1607.95|1|3|0|C||3||1|8.03641|4158|1|
L01BA04|PEMETREXED|LH375|Armisarte|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 20 ml|mg|1|500|Actavis Group PTC ehf., |767.53|1|2|0|C|7|1||1|1.524|4220|1|
L01BA04|PEMETREXED|LH376|Armisarte|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 40 ml|mg|1|1000|Actavis Group PTC ehf., |1535.06|1|2|0|C|7|1||1|1.524|4221|1|
L01AX03|TEMOZOLOMIDE|LH379|Temozolomide Accord|CAPSULE, HARD|100 mg|mg|5|500|Accord Healthcare S.L.U., |61.85|4|0|0|C|3|1||0|0.12349|4195|1|
L01BC02|FLUOROURACIL|LH382|5-Fluorouracil Ebewe|CONCENTRATE FOR SOL. FOR INJECTION/INFUSION|50 mg/ml - 20 ml|mg|10|10000|Ebewe Pharma GmbH. N.fg. KG, |92.75|1|4|0|C|8|1||1|0.00817|15089|1|
L03AX03|Mycobacterium bovis BCG|LH386|CALGEVAX|Powder for suspension|11.25|mg|4|45| - , |207.89|1|4|0|C|6|4||0|4.61874|4210|1|
L01EL01|IBRUTINIB|LH390|Imbruvica|CAPSULE, HARD|140|mg|90|12600|Janssen-Cilag International N.V., |11223.84|4|0|0|C|3|3||0|0.89078|15533|1|
L01EK01|AXITINIB|LH393|Inlyta|TABL. FILM. COAT.|1 mg|mg|56|56|Pfizer Europe MA EEIG, |475.26|4|0|0|C|3|3||0|19.14743|15567|1|
L01FF02|EMBROLIZUMAB|LH399|Keytruda|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 4ml|mg|1|100|Merck Sharp & Dohme B.V., |5529.77|1|2|0|C||4||0|56.31468|15839|1|
L01EA01|IMATINIB|LH402|Imatinib Teva Pharma|TABL. FILM. COAT.|100 mg|mg|120|12000|Teva B.V, |160.3|4|0|0|C|3|3||0|0.0132|15855|1|
L01EB02|ERLOTINIB|LH404|Erlotinib Sandoz|TABL. FILM. COAT.|100 mg|mg|30|3000|Sandoz d.d., |541.55|4|0|0|C|3|3||0|0.18048|15910|1|
L01EB02|ERLOTINIB|LH405|Erlotinib Actavis|FILM-COATED TABLET|100 mg|mg|30|3000|Teva B.V, |541.55|4|0|0|C|3|3||0|0.18048|15917|1|
L01EB02|ERLOTINIB|LH406|Erlotinib Actavis|FILM-COATED TABLET|150 mg|mg|30|4500|Teva B.V, |812.33|4|0|0|C|3|3||0|0.18048|15918|1|
L01FA03|OBINUTUZUMAB|LH409|Gazyvaro|CONCENTRATE FOR SOLUTION FOR INFUSION|1000 mg - 40 ml|mg|1|1000|Roche Registration GmbH, |4974.44|1|4|0|C||3||1|4.97444|9051|1|
L01FF01|NIVOLUMAB|LH410|Opdivo|CONCENTRATE FOR SOLUTION FOR INFUSION|10 MG/ML - 10 ML|mg|1|100|Bristol-Myers Squibb Pharma EEIG, |2273.13|1|2|0|C||4||1|22.72616|15972|1|
L01FF01|NIVOLUMAB|LH411|Opdivo|CONCENTRATE FOR SOLUTION FOR INFUSION|10 mg/ml-4ml|mg|1|40|Bristol-Myers Squibb Pharma EEIG, |909.25|1|2|0|C||4||1|22.72616|15971|1|
L01FX07|BLINATUMOMAB|LH412|Blincyto|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|38.5mg|mcg|1|38.5|Amgen Eurpe B.V., |4750.51|1|2|0|C||3||1|124.10857|15954|1|
L01EX05|REGORAFENIB|LH414|Stivarga|FILM-COATED TABLET|40 mg|mg|84|3360|Bayer AG, |4480.26|4|0|0|C|3|3||0|1.33279|8906|1|
L01EA05|PONATINIB|LH415|Iclusig|FILM-COATED TABLET|15 mg|mg|60|900|Incyte Biosciences Distribution B.V., |10837.56|4|0|0|C|3|3||0|12.27654|15297|1|
L01EF01|PALBOCICLIB|LH416|Ibrance|CAPSULE, HARD|75 mg|mg|21|1575|Pfizer Europe MA EEIG, |2107.26|4|0|0|C|3|3||0|1.40769|15722|1|
L01EF01|PALBOCICLIB|LH417|Ibrance|CAPSULE, HARD|100 mg|mg|21|2100|Pfizer Europe MA EEIG, |2809.67|4|0|0|C|3|3||0|1.40769|15724|1|
L01EF01|PALBOCICLIB|LH418|Ibrance|CAPSULE, HARD|125 mg|mg|21|2625|Pfizer Europe MA EEIG, |3512.08|4|0|0|C|3|3||0|1.40769|15723|1|
L01EB04|OSIMERTINIB|LH419|Tagrisso|FILM-COATED TABLET|40 mg|mg|28|1120|Astra Zeneca AB, |5503.92|4|0|0|C|3|3||0|4.91353|15969|1|
L01EB04|OSIMERTINIB|LH420|Tagrisso|FILM-COATED TABLET|80 mg|mg|28|2240|Astra Zeneca AB, |11007.84|4|0|0|C|3|3||0|4.91353|15785|1|
L01XG02|CARFILZOMIB|LH421|Kyprolis|POWDER FOR SOLUTION FOR INFUSION|60 mg|mg|1|60|Amgen Eurpe B.V., |2080.25|1|4|0|C||3||1|34.67076|15897|1|
L01XX52|venetoclax|LH426|Venclyxto|Film coated tablet|100|mg|112|11200|AbbVie Deutchland GmbH & Co. KG, |9919.87|4|0|0|C|3|3||0|0.88547|15958|1|
L01EB02|ERLOTINIB|LH427|Erlotinib Sandoz|TABL. FILM. COAT.|150 mg|mg|30|4500|Sandoz d.d., |812.33|4|0|0|C|3|3||0|0.18048|15938|1|
L01AA01|Cyclophosphamide|LH430|Endoxan|Powder for solution for injection|500|mg|1|500|  , |20.3|1|4|0|C|7|1||1|0.03479|15853|1|
L01XG01|BORTEZOMIB|LH432|Bortezocon|POWDER FOR SOLUTION FOR INJECTION|3.5 mg|mg|1|3.5| , |150|1|4|0|C||3||1|42.84754|15990|1|
L01AA06|Ifosfamide|LH433|Holoxan|Powder for solution for infusion|2000|mg|1|2000|  , |221.87|1|4|0|C||1||1|0.10698|15975|1|
L01XA03|OXALIPLATIN|LH435|Oxaliplatin Bulgermed|CONCENTRATE FOR SOLUTION FOR INFUSION|5 mg/ml - 20 ml|mg|1|100|  , |29.86|1|3|0|C||1||1|0.30432|16038|1|
L01FA01|RITUXIMAB|LH436|Truxima|CONCENTRATE FOR SOLUTION FOR INFUSION|100 mg|mg|2|200|Celltrion Healthcare Hungary Kft., |244.54|1|4|0|C||3||1|1.22243|15909|1|
L01FA01|RITUXIMAB|LH437|Truxima|CONCENTRATE FOR SOLUTION FOR INFUSION|500 mg|mg|1|500|Celltrion Healthcare Hungary Kft., |611.35|1|4|0|C||3||1|1.22243|15911|1|
L01BB06|CLOFARABINE|LH439|Clofarabin Zentiva|CONCENTRATE FOR SOLUTION FOR INFUSION|1mg/ml - 20ml|mg|1|20|Zentiva k.s.,  |1311.18|1|4|0|C||1||1|52.774|16011|1|
L03AA02|FILGRASTIM|LH442|Accofil|CONCENTRATE FOR SOL. FOR INJECTION/INFUSION|30 MU (300 mcg/0.5 ml)|mcg|5|1500|Accord Healthcare S.L.U., |108.13|3|1|0|C|7|5||0|0.072|16007|0|
L01BA01|METHOTREXATE|LH443|Methotrexate Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|100 mg/ml - 10 ml|mg|1|1000|Accord Healthcare Polska , |32.99|1|4|0|C||1||1|0.03292|15946|1|
L01FD01|TRASTUZUMAB|LH444|Kanjinti|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|150 mg|mg|1|150|Amgen Eurpe B.V., |271.72|1|4|0|C||3||1|2.48744|16188|1|
L01FD01|TRASTUZUMAB|LH445|Kanjinti|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|420 MG|mg|1|420|Amgen Eurpe B.V., |760.82|1|4|0|C||3||1|2.48744|16189|1|
L01CE02|IRINOTECAN|LH446|Irinotecan Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 5 ml|mg|1|100|Accord Healthcare Polska , |24.88|1|3|0|C||1||1|0.24874|16166|1|
L02BX03|ABIRATERONE ACETATE|LH447|Zytiga|TABLETS FILM COATED|500 mg|mg|60|30000|Janssen-Cilag International N.V., |543.6|4|0|0|C|3|2||0|0.01812|16148|1|
L01CB01|ETOPOSIDE|LH450|Etoposide Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 5 ml|mg|1|100|Accord Healthcare Polska , |11.98|1|4|0|C||1||1|0.11961|16266|1|
L01FA01|RITUXIMAB|LH454|Rixathon|CONCENTRATE FOR SOLUTION FOR INFUSION|100 mg/10 ml|mg|2|200|Sandoz GmbH, |244.54|1|4|0|C||3||1|1.22243|16316|1|
L01FA01|RITUXIMAB|LH455|Rixathon|CONCENTRATE FOR SOLUTION FOR INFUSION|500 mg/50 ml|mg|1|500|Sandoz GmbH, |611.35|1|4|0|C||3||1|1.22243|16315|1|
L01CD01|PACLITAXEL|LH456|Paclitaxel Bulgermed|CONCENTRATE FOR SOLUTION FOR INFUSION|6 mg/ml - 50 ml|mg|1|300|  , |84.57|1|4|0|C||1||1|0.21976|16346|1|
L01XG01|BORTEZOMIB|LH457|Bortezomib Sandoz|POWDER FOR SOLUTION FOR INJECTION|3.5 mg|mg|1|3.5|Sandoz d.d., |150|1|4|0|C||3||1|42.84754|16347|1|
L01FA01|RITUXIMAB|LH458|MabThera|SOLUTION FOR INJECTION|1600 mg/13.4 ml|mg|1|1600|Roche Registration GmbH, |3350.51|3|1|0|C||3||0|2.09406|16352|1|
L01BC59|TRIFLURIDINE/TIPIRACIL|LH459|Lonsurf|TABL. FILM. COAT.|15mg/6.14mg|MG|20|300|Les Laboratoires Servier, |893.78|4|0|0|C|3|1||0|53.08045|15584|1|
L01CD02|DOCETAXEL|LH460|Docetaxel Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|160 mg/ 8 ml|mg|1|160|Accord Healthcare S.L.U., |65.9|1|2|0|C||1||1|0.41535|2865|1|
L01BC59|TRIFLURIDINE/TIPIRACIL|LH461|Lonsurf|TABL. FILM. COAT.|20mg/8.19mg|MG|20|400|Les Laboratoires Servier, |1187.7|4|0|0|C|3|1||0|70.57337|15583|1|
L01XA03|OXALIPLATIN|LH463|Oxaliplatin Bulgermed|CONCENTRATE FOR SOLUTION FOR INFUSION|5 MG/ML - 40 ML|mg|1|200|  , |59.72|1|3|0|C||1||1|0.30432|16372|1|
L01FC01|DARATUMUMAB|LH464|DARZALEX|CONCENTRATE FOR SOLUTION FOR INFUSION|20 MG/ ML - 20ML|mg|1|400|Janssen-Cilag International N.V., |3236.6|1|4|0|C||4||1|8.0915|16383|1|
L01ED03|ALECTINIB|LH465|Alecensa|CAPSULE, HARD|150 mg|mg|224|33600|Roche Registration GmbH, |8525.82|4|0|0|C|3|3||0|0.28189|15874|1|
L01XG03|IXAZOMIB|LH466|Ninlaro|CAPSULE, HARD|2.3 mg|mg|3|6.9|Takeda Pharma A/S, |4541.3|4|0|0|C|3|3||0|657.83009|16389|1|
L01XG03|IXAZOMIB|LH467|Ninlaro|CAPSULE, HARD|3 mg|mg|3|9|Takeda Pharma A/S, |5923.43|4|0|0|C|3|3||0|657.83009|16390|1|
L01XG03|IXAZOMIB|LH468|Ninlaro|CAPSULE, HARD|4 mg|mg|3|12|Takeda Pharma A/S, |7897.91|4|0|0|C|3|3||0|657.83009|16391|1|
L01FB01|INOTUZUMAB OZOGAMICIN|LH469|BESPONSA|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|1 mg|mg|1|1|Pfizer Europe MA EEIG, |16469.14|1|4|0|C||4||1|18314.45557|16071|1|
L01FF05|ATEZOLIZUMAB|LH470|Tecentriq|CONCENTRATE FOR SOLUTION FOR INFUSION|1200 mg - 20 ml|mg|1|1200|Roche Registration GmbH, |7487.82|1|2|0|C||4||0|6.24308|16088|1|
L01EG02|EVEROLIMUS|LH471|Everolimus Viatris|TABLET|5 mg|mg|30|150|Viatris Limited, |678.4|4|0|0|C|3|3||0|4.518|16405|1|
L01EG02|EVEROLIMUS|LH472|Everolimus Viatris|TABLET|10 mg|mg|30|300|Viatris Limited, |1356.8|4|0|0|C|3|3||0|4.518|16406|1|
L01EG02|EVEROLIMUS|LH473|Everolimus Teva|TABLET|10 mg|mg|30|300|Teva B.V, |1356.8|4|0|0|C|3|3||0|4.518|16132|1|
L01FD01|TRASTUZUMAB|LH474|Trazimera|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|150 mg|MG|1|150|Pfizer Europe MA EEIG, |271.72|1|4|0|C||3||1|2.48744|16472|1|
L03AA13|PEGFILGRASTIM|LH476|Pelgraz|SOLUTION FOR INJECTION|10mg/ml-0.6 ml|mg|1|6|Accord Healthcare S.L.U., |560.62|3|1|0|C|7|5||0|93.38995|16452|0|
L03AA13|PEGFILGRASTIM|LH477|Ziextenzo|SOLUTION FOR INJECTION|10mg/ml-0.6 ml|mg|1|6|Sandoz GmbH, |560.62|3|1|0|C|7|5||0|93.38995|16451|0|
L01FD01|TRASTUZUMAB|LH478|Ogivri|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|150 mg|mg|1|150|Biosimilar Collaborations Ireland Limited, |271.72|1|4|0|C||3||1|2.48744|16471|1|
L01XG02|CARFILZOMIB|LH479|Kyprolis|POWDER FOR SOLUTION FOR INFISION|10 mg|mg|1|10|Amgen Eurpe B.V., |346.71|1|4|0|C||3||1|34.67076|16496|1|
L01XG02|CARFILZOMIB|LH480|Kyprolis|POWDER FOR SOLUTION FOR INFISION|30 mg|mg|1|30|Amgen Eurpe B.V., |1040.12|1|4|0|C||3||1|34.67076|16497|1|
L01CE02|IRINOTECAN|LH483|Irinotecan Bulgermed|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 5 ml|MG|1|100|  , |24.88|1|3|0|C||1||1|0.24874|16545|1|
L01XK01|OLAPARIB|LH484|Lynparza|TABL. FILM. COAT.|150 mg|MG|56|8400|Astra Zeneca AB, |4732.68|4|0|0|C|3|3||0|0.58312|16571|1|
L01XK01|OLAPARIB|LH485|Lynparza|TABL. FILM. COAT.|100 mg|MG|56|5600|Astra Zeneca AB, |3153.99|4|0|0|C|3|3||0|0.58312|16570|1|
L01FC01|DARATUMUMAB|LH490|DARZALEX|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 5 ml|mg|1|100|Janssen-Cilag International N.V., |809.15|1|4|0|C||4||1|8.0915|16382|1|
L01FX02|GEMTUZUMAB OZOGAMICIN|LH491|Mylotarg|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|5 mg|mg|1|5|Pfizer Europe MA EEIG, |13747.44|1|4|0|C|7|4||1|2748.86653|16703|1|
L01FF03|DURVALUMAB|LH492|Imfinzi|CONCENTRATE FOR SOLUTION FOR INFUSION|50 mg/ml - 10 ml|mg|1|500|Astra Zeneca AB, |4051.76|1|3|0|C||3||1|8.52995|16712|1|
L01FF03|DURVALUMAB|LH493|Imfinzi|CONCENTRATE FOR SOLUTION FOR INFUSION|50 mg/ml - 2.4 ml|mg|1|120|Astra Zeneca AB, |972.42|1|3|0|C||3||1|8.52995|16711|1|
L01EE01|TRAMETINIB|LH494|Mekinist|FILM-COATED TABLET|2 mg|mg|30|60|Novartis Europharm Ltd., |7625.33|4|0|0|C|3|3||0|127.0542|15093|1|
L01EX10|MIDOSTAURIN|LH495|Rydapt|CAPS. SOFT|25 mg|mg|112|2800|Novartis Europharm Ltd., |24303.34|4|0|0|C|3|3||0|8.67785|16111|1|
L01EF02|RIBOCICLIB|LH497|Kisqali|FILM-COATED TABLET|200 mg|mg|21|4200|Novartis Europharm Ltd., |1608.98|4|0|0|C|3|3||0|0.39412|16147|1|
L01EE02|COBIMETINIB|LH498|Cotellic|TABL. FILM. COAT.|20 mg|mg|63|1260|Roche Registration GmbH, |10318.86|4|0|0|C|3|3||0|8.18774|15005|1|
L01CD02|DOCETAXEL|LH501|Docetaxel Novamed|CONCENTRATE FOR SOLUTION FOR INFUSION|20mg/ml-8ml|mg|1|160|  , |65.9|1|2|0|C||1||1|0.41535|16740|1|
L01CD02|DOCETAXEL|LH502|Docetaxel Novamed|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 4 ml|mg|1|80|  , |32.95|1|2|0|C||1||1|0.41535|16741|1|
L01CE02|IRINOTECAN|LH503|IRINOTECAN NOVAMED|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 5 ml|mg|1|100|  , |24.88|1|3|0|C||1||1|0.24874|16106|1|
L01FF04|AVELUMAB|LH504|Bavencio|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 10 ml|mg|1|200|Merck Europe B.V., |1540.69|1|3|0|C||4||1|7.69613|16743|1|
L01AA09|BENDAMUSTINE HYDROCHLORIDE|LH505|Bendamustine Sandoz|POWDER FOR CONCENTRATE SOLUTION FOR INFUSION|100 mg|mg|1|100|Sandoz d.d., |77.5|1|4|0|C|6|1||1|0.81458|16773|1|
L01EF03|ABEMACICLIB|LH506|Verzenios|TABL. FILM. COAT.|150 mg|mg|42|6300|Eli Lilly Nederland B.V., |3863.94|4|0|0|C|3|3||0|0.61319|16779|1|
L01EF03|ABEMACICLIB|LH507|Verzenios|TABL. FILM. COAT.|100 mg|mg|42|4200|Eli Lilly Nederland B.V., |2575.96|4|0|0|C|3|3||0|0.61319|16780|1|
L01EF03|ABEMACICLIB|LH508|Verzenios|TABL. FILM. COAT.|50 mg|mg|42|2100|Eli Lilly Nederland B.V., |1287.98|4|0|0|C|3|3||0|0.61319|16781|1|
L01XF03|BEXAROTENE|LH509|Targretin|CAPSULE, SOFT|75 mg|mg|100|7500|Eisai GmbH, |956.03|4|0|0|C|3|3||0|0.12746|16778|1|
L01EX09|NINTEDANIB|LH510|Vargatef|CAPSULE, SOFT|150 mg|mg|60|9000|Boehringer Ingelheim International GmbH, |3570.1|4|0|0|C|3|1||0|0.39651|16730|1|
L01EX09|NINTEDANIB|LH511|Vargatef|CAPSULE, SOFT|100 mg|mg|120|12000|Boehringer Ingelheim International GmbH, |4761.14|4|0|0|C|3|1||0|0.39651|16731|1|
L01XX24|PEGASPARGASE|LH512|Oncaspar|POWD.FOR SOL. FOR INJ/INF|750 U/ml - 3750 U|IU|1|3750|Les Laboratoires Servier, |3441.17|1|3|0|C||1||1|0.91719|16704|1|
L01XE43|BRIGATINIB|LH517|Alunbrig|TABL. FILM. COAT.|30 mg|mg|28|840|Takeda Pharma A/S, |1354.54|4|0|0|C|3|3||0|1.64237|16830|1|
L01XE43|BRIGATINIB|LH518|Alunbrig|TABL. FILM. COAT.|90 mg|mg|28|2520|Takeda Pharma A/S, |4063.63|4|0|0|C|3|3||0|1.64237|16832|1|
L01XE43|BRIGATINIB|LH519|Alunbrig|TABL. FILM. COAT.|180 mg|mg|28|5040|Takeda Pharma A/S, |8127.23|4|0|0|C|3|3||0|1.64237|16833|1|
L04AX06|POMALIDOMIDE|LH520|Imnovid|CAPSULE, HARD|4 mg|mg|21|84|Bristol-Myers Squibb Pharma EEIG, |3861.38|4|0|0|C|3|1||0|45.94618|16829|1|
L02BB04|ENZALUTAMIDE|LH522|Xtandi|TABL. FILM. COAT.|40 mg|mg|112|4480|Astellas Pharma Europe B.V., |4994.99|4|0|0|C|3|2||0|1.23161|16624|1|
L01FF05|ATEZOLIZUMAB|LH523|Tecentriq|CONCENTRATE FOR SOLUTION FOR INFUSION|840mg - 14ml|mg|1|840|Roche Registration GmbH, |5241.47|1|2|0|C||4||0|6.24308|16860|1|
L01CD01|PACLITAXEL|LH524|Pazenir|POWDER FOR DISPERSION FOR INFUSION|5mg/ml (100mg)|mg|1|100|Ratiopharm GmbH, |270.36|1|3|0|C||1||1|2.70225|16868|1|
L01EB01|GEFITINIB|LH526|Gefitinib Pharmascience|FILM-COATED TABLET|250 mg|mg|30|7500|Pharmascience International Ltd., |774.77|4|0|0|C|3|3||0|0.03152|16885|1|
L01XE43|BRIGATINIB|LH528|Alunbrig|TABL. FILM. COAT.|90 mg + 180 mg|mg|28|4410|Takeda Pharma A/S, |7111.35|4|0|0|C|3|3||0|1.64237|16976|1|
L01BC05|GEMCITABINE|LH529|Gemsol|CONCENTRATE FOR SOLUTION FOR INFUSION|40 mg/ml - 25 ml|MG|1|1000|Ebewe Pharma GmbH. N.fg. KG, |35.92|1|4|0|C|8|1||1|0.03588|16985|1|
L01CD02|DOCETAXEL|LH530|Docetaxel Bulgermed|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 4 ml|MG|1|80|  , |32.95|1|2|0|C||1||1|0.41535|17009|1|
L01CD02|DOCETAXEL|LH531|Docetaxel Bulgermed|CONCENTRATE FOR SOLUTION FOR INFUSION|20mg/ml-8ml|MG|1|160|  , |65.9|1|2|0|C||1||1|0.41535|17010|1|
L01BB07|NELARABINE|LH532|Atriance|SOLUTION FOR INFUSION|5 mg/ml - 50ml|mg|1|250|Sandoz Pharmaceuticals d.d., |565.04|1|4|0|C||1||1|2.21584|16987|1|
L01XA03|OXALIPLATIN|LH534|Oxaliplatin Ebewe|CONCENTRATE FOR SOLUTION FOR INFUSION|5 mg/ml - 20 ml|mg|1|100|Ebewe Pharma GmbH. N.fg. KG, |29.86|1|3|0|C||1||1|0.30432|17039|1|
L01FG01|BEVACIZUMAB|LH535|MVASI|CONCENTRATE FOR SOLUTION FOR INFUSION|25mg/ml - 16ml|mg|1|400|Amgen Technology (Ireland) UC, |614.54|1|4|0|C|8|3||1|2.34747|17076|1|
L01FG01|BEVACIZUMAB|LH536|MVASI|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 4ml|mg|1|100|Amgen Technology (Ireland) UC, |156.33|1|4|0|C|8|3||1|2.34747|17075|1|
L01EX08|LENVATINIB|LH537|Lenvima|CAPSULE, HARD|4 mg|mg|30|120|Eisai GmbH, |2408.94|4|0|0|C|3|3||0|20.05997|17079|1|
L01FG01|BEVACIZUMAB|LH538|Zirabev|CONCENTRATE FOR SOLUTION FOR INFUSION|25mg/ml - 16ml|MG|1|400|Pfizer Europe MA EEIG, |614.54|1|4|0|C|8|3||1|2.34747|17139|1|
L01FG01|BEVACIZUMAB|LH539|Zirabev|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 4ml|MG|1|100|Pfizer Europe MA EEIG, |156.33|1|4|0|C|8|3||1|2.34747|17138|1|
L01CE02|IRINOTECAN|LH540|Onivyde pegylated liposomal|CONCENTRATE FOR DISPERSION FOR INFUSION|4.3 mg/ml - 10 ml|mg|1|43|Les Laboratoires Servier, |1866.17|1|4|0|C|7|1||1|43.39079|16622|1|
L02BB05|APALUTAMIDE|LH541|Erleada|TABL. FILM. COAT.|60 mg|mg|120|7200|Janssen-Cilag International N.V., |5413.33|4|0|0|C|3|3||0|0.81022|17140|1|
L04AX04|LENALIDOMIDE|LH543|Lenalidomide Sandoz|CAPSULE, HARD|10 mg|mg|21|210|Sandoz d.d., |262.98|4|0|0|C|3|1||0|2.57036|17113|1|
L04AX04|LENALIDOMIDE|LH544|Lenalidomide Sandoz|CAPSULE, HARD|25 mg|mg|21|525|Sandoz d.d., |657.44|4|0|0|C|3|1||0|2.57036|17114|1|
L01FF06|CEMIPLIMAB|LH545|Libtayo|CONCENTRATE FOR SOLUTION FOR INFUSION|350 mg|mg|1|350|Regeneron Ireland Designated Activity Company (DAC), |7257.18|1|2|0|C|3|3||0|22.27881|17178|1|
L01EX13|GILTERITINIB|LH546|Xospata|TABL. FILM. COAT.|40 mg|mg|84|3360|Astellas Pharma Europe B.V., |35326.87|4|0|0|C|3|1||0|10.54257|17152|1|
L04AX04|LENALIDOMIDE|LH547|Lenalidomide Pharmascience|CAPSULE, HARD|25 mg|mg|21|525|Pharmascience International Ltd., |657.44|4|0|0|C|3|1||0|2.57036|17186|1|
L01BA04|PEMETREXED|LH548|Pemetrexed Sandoz|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 20 ml|mg|1|500|Sandoz d.d., |767.53|1|2|0|C|7|1||1|1.524|17199|1|
L01BA04|PEMETREXED|LH549|Pemetrexed Sandoz|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 40 ml|mg|1|1000|Sandoz d.d., |1535.06|1|2|0|C|7|1||1|1.524|17200|1|
L04AX04|LENALIDOMIDE|LH550|Lenalidomide Pharmascience|CAPSULE, HARD|5 mg|mg|21|105|Pharmascience International Ltd., |131.49|4|0|0|C|3|1||0|2.57036|17223|1|
L04AX04|LENALIDOMIDE|LH551|Lenalidomide Pharmascience|CAPSULE, HARD|10 mg|mg|21|210|Pharmascience International Ltd., |262.98|4|0|0|C|3|1||0|2.57036|17224|1|
L01BC07|AZACITIDINE|LH552|Azacitidine Sandoz|POWD.SUSP|25mg/ml|mg|1|100|Sandoz d.d., |137.21|3|1|0|C||1||1|1.7815|17226|1|
L01BC07|AZACITIDINE|LH553|Azacitidine Pharmascience|POWDER FOR SUSPENSION FOR INJECTION|25 mg/ml (1 vial x 150 mg)|mg|1|150|Pharmascience International Ltd., |205.82|3|1|0|C||1||1|1.7815|17305|1|
L01BC07|AZACITIDINE|LH554|Azacitidine Pharmascience|POWDER FOR SUSPENSION FOR INJECTION|25 mg/ml (1 vial x 100 mg)|mg|1|100|Pharmascience International Ltd., |137.21|3|1|0|C||1||1|1.7815|17306|1|
L01EX02|SORAFENIB|LH555|Sorafenib Pharmascience|TABL. FILM. COAT.|200 mg|mg|112|22400|Pharmascience International Ltd., |1385.56|4|0|0|C|3|3||0|0.0618|17302|1|
L01EX02|SORAFENIB|LH556|Nexavar|TABL. FILM. COAT.|200 mg|mg|112|22400|Bayer AG, |2649.13|4|0|0|C|3|3||0|0.11823|3435|1|
L01ED05|LORLATINIB|LH558|Lorviqua|TABL. FILM. COAT.|100 mg|mg|30|3000|Pfizer Europe MA EEIG, |8461.19|4|0|0|C|3|3||0|2.81934|16795|1|
L01FG01|BEVACIZUMAB|LH559|Alymsys|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 4ml|mg|1|100|Mabxience Research SL, |156.33|1|3|0|C|8|3||1|2.34747|17390|1|
L01FG01|BEVACIZUMAB|LH560|Alymsys|CONCENTRATE FOR SOLUTION FOR INFUSION|25mg/ml - 16ml|mg|1|400|Mabxience Research SL, |614.54|1|3|0|C|8|3||1|2.34747|17389|1|
L01EX01|SUNITINIB|LH571|Suniticon|CAPSULE, HARD|50 mg|mg|30|1500| , |1173.28|4|0|0|C|3|3||0|0.78|17490|1|
L01EX01|SUNITINIB|LH572|Suniticon|CAPSULE, HARD|12.5 mg|mg|30|375| , |293.32|4|0|0|C|3|3||0|0.78|17489|1|
L01EG02|EVEROLIMUS|LH576|Everolimus Sandoz|TABLET|10 mg|mg|30|300|Sandoz d.d., |1356.8|4|0|0|C|3|3||0|4.518|17521|1|
L01ED05|LORLATINIB|LH577|Lorviqua|TABL. FILM. COAT.|25 mg|mg|90|2250|Pfizer Europe MA EEIG, |6345.9|4|0|0|C|3|3||0|2.81934|17262|1|
L01EB01|GEFITINIB|LH578|Gefiticon|TABL. FILM. COAT.|250 mg|mg|30|7500| , |774.77|4|0|0|C|3|3||0|0.03152|17511|1|
L02BB06|DAROLUTAMIDE|LH579|Nubeqa|FILM-COATED TABLET|300 mg|mg|112|33600|Bayer AG, |6421.96|4|0|0|C|3|3||0|0.19109|17538|1|
L01BC07|AZACITIDINE|LH580|Azacitidine Stada Arzneimittel|POWDER FOR SUSPENSION FOR INJECTION|25 mg/ml (1 vial x 100 mg)|mg|1|100|Stada Arzneimittel AG, |137.21|3|1|0|C||1||1|1.7815|17397|1|
L01FG01|BEVACIZUMAB|LH581|Oyavas|CONCENTRATE FOR SOLUTION FOR INFUSION|25mg/ml - 16ml|mg|1|400|Stada Arzneimittel AG, |614.54|1|3|0|C|8|3||1|2.34747|17380|1|
L01FG01|BEVACIZUMAB|LH582|Oyavas|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 4ml|mg|1|100|Stada Arzneimittel AG, |156.33|1|3|0|C|8|3||1|2.34747|17379|1|
L01BC07|AZACITIDINE|LH583|Azacitidine Accord|POWDER FOR SUSPENSION FOR INJECTION|25 mg/ml (1 vial x 100 mg)|mg|1|100|Accord Healthcare S.L.U., |137.21|3|1|0|C||1||1|1.7815|17566|1|
L01EC03|ENCORAFENIB|LH584|Braftovi|CAPSULE, HARD|75 mg|mg|42|3150|Pierre Fabre Medicament, |2397.49|4|0|0|C|3|3||0|0.76831|17596|1|
L01EC03|ENCORAFENIB|LH585|Braftovi|CAPSULE, HARD|50 mg|mg|28|1400|Pierre Fabre Medicament, |1065.18|4|0|0|C|3|3||0|0.76831|17595|1|
L01EE03|BINIMETINIB|LH586|Mektovi|FILM-COATED TABLET|15 mg|mg|84|1260|Pierre Fabre Medicament, |3477.7|4|0|0|C|3|3||0|2.76008|17594|1|
L01EX14|ENTRECTINIB|LH587|Rozlytrek|CAPSULE, HARD|200 mg|mg|90|18000|Roche Registration GmbH, |9972.72|4|0|0|C|3|3||0|0.55806|17299|1|
L01FX14|POLATUZUMAB VEDOTIN|LH588|Polivy|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|140 mg|mg|1|140|Roche Registration GmbH, |20352.68|1|2|0|C|0|4||1|145.34393|17214|1|
L01FX14|POLATUZUMAB VEDOTIN|LH589|Polivy|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|30 mg|mg|1|30|Roche Registration GmbH, |4361.29|1|2|0|C|0|4||1|145.34393|18061|1|
L01FY01|PERTUZUMAB, TRASTUZUMAB|LH594|Phesgo|SOLUTION FOR INJECTION|1200 mg/600 mg - 15ml|mg|1|1800|Roche Registration GmbH, |8568.56|3|1|0|C|7|3||0|5.99848|18063|1|
L01FY01|PERTUZUMAB, TRASTUZUMAB|LH595|Phesgo|SOLUTION FOR INJECTION|600 mg/600 mg - 10 ml|mg|1|1200|Roche Registration GmbH, |4747.34|3|1|0|C|7|3||0|4.99294|18064|1|
L04AX04|LENALIDOMIDE|LH596|Lenalidomide Pharmascience|CAPSULE, HARD|15 mg|mg|21|315|Pharmascience International Ltd., |394.46|4|0|0|C|3|1||0|2.57036|17576|1|
L01EX01|SUNITINIB|LH597|Sunitinib Teva|CAPSULE, HARD|50 mg|mg|30|1500|Teva B.V, |1173.28|4|0|0|C|3|3||0|0.78|61749|1|
L01EX01|SUNITINIB|LH598|Sunitinib Teva|CAPSULE, HARD|25 mg|mg|30|750|Teva B.V, |586.64|4|0|0|C|3|3||0|0.78|61742|1|
L01EX02|SORAFENIB|LH600|Sorafecon|FILM-COATED TABLET|200 mg|mg|112|22400| , |1385.56|4|0|0|C|3|3||0|0.0618|58316|1|
L01CD04|CABAZITAXEL|LH601|Cabazitaxel Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 3ml|mg|1|60|Accord Healthcare S.L.U., |1414.99|1|2|0|C|7|1||1|23.57121|77090|1|
L01CD04|CABAZITAXEL|LH602|Eleber|CONCENTRATE AND SOLVENT FOR SOLUTION FOR INFUSION|60 mg|mg|1|60|Zentiva k.s.,  |1414.99|1|2|0|C|7|1||1|23.57121|27497|1|
L01EX01|SUNITINIB|LH608|Sunitinib Pharmascience|CAPSULE, HARD|50 mg|mg|30|1500|Pharmascience International Ltd., |1173.28|4|0|0|C|3|3||0|0.78|27563|1|
L01EX01|SUNITINIB|LH609|Sunitinib Pharmascience|CAPSULE, HARD|37.5 mg|mg|30|1125|Pharmascience International Ltd., |879.96|4|0|0|C|3|3||0|0.78|27561|1|
L01EX01|SUNITINIB|LH610|Sunitinib Pharmascience|CAPSULE, HARD|12.5 mg|mg|30|375|Pharmascience International Ltd., |293.32|4|0|0|C|3|3||0|0.78|27554|1|
L01EX01|SUNITINIB|LH611|Sunitinib Pharmascience|CAPSULE, HARD|25 mg|mg|30|750|Pharmascience International Ltd., |586.64|4|0|0|C|3|3||0|0.78|27557|1|
L01EX01|SUNITINIB|LH612|Sunitinib Sandoz|CAPSULE, HARD|50 mg|mg|30|1500|Sandoz d.d., |1173.28|4|0|0|C|3|3||0|0.78|30292|1|
L01EX01|SUNITINIB|LH613|Sunitinib Sandoz|CAPSULE, HARD|25 mg|mg|30|750|Sandoz d.d., |586.64|4|0|0|C|3|3||0|0.78|30311|1|
L01EX01|SUNITINIB|LH614|Sunitinib Sandoz|CAPSULE, HARD|12.5 mg|mg|30|375|Sandoz d.d., |293.32|4|0|0|C|3|3||0|0.78|30273|1|
L04AX04|LENALIDOMIDE|LH615|Lenalidomide Grindeks|CAPSULE, HARD|5 mg|mg|21|105|AS Grindeks, |131.49|4|0|0|C|3|1||0|2.57036|17412|1|
L04AX04|LENALIDOMIDE|LH616|Lenalidomide Grindeks|CAPSULE, HARD|10 mg|mg|21|210|AS Grindeks, |262.98|4|0|0|C|3|1||0|2.57036|17413|1|
L04AX04|LENALIDOMIDE|LH617|Lenalidomide Grindeks|CAPSULE, HARD|25 mg|mg|21|525|AS Grindeks, |657.44|4|0|0|C|3|1||0|2.57036|17303|1|
L01FC01|DARATUMUMAB|LH619|Darzalex|SOLUTION FOR INJECTION|1800 mg-15 ml|mg|1|1800|Janssen-Cilag International N.V., |9644.7|3|1|0|C||4||0|5.45543|47299|1|
L01EX03|PAZOPANIB|LH620|Pazopanib Pharmascience|TABLETS FILM COATED|400 mg|mg|60|24000|Pharmascience International Ltd., |1352.44|4|0|0|C|3|3||0|0.054|58367|1|
L01EX03|PAZOPANIB|LH621|Pazopanib Pharmascience|TABLETS FILM COATED|200 mg|mg|30|6000|Pharmascience International Ltd., |338.11|4|0|0|C|3|3||0|0.054|58353|1|
L01EX01|SUNITINIB|LH625|Sunitinib Accord|CAPSULE, HARD|25 mg|mg|30|750|Accord Healthcare S.L.U., |586.64|4|0|0|C|3|3||0|0.78|54389|1|
L01EX01|SUNITINIB|LH626|Sunitinib Accord|CAPSULE, HARD|50 mg|mg|30|1500|Accord Healthcare S.L.U., |1173.28|4|0|0|C|3|3||0|0.78|54395|1|
L01EA01|IMATINIB|LH627|Imatinib Accord|TABLETS FILM COATED|100 mg|mg|120|12000|Accord Healthcare S.L.U., |160.3|4|0|0|C|3|3||0|0.0132|49028|1|
L01EX03|PAZOPANIB|LH628|Alunib|TABLETS FILM COATED|400 mg|mg|60|24000|  , |1352.44|4|0|0|C|3|3||0|0.054|58193|1|
L01EX03|PAZOPANIB|LH629|Alunib|TABLETS FILM COATED|200 mg|mg|30|6000|  , |338.11|4|0|0|C|3|3||0|0.054|58186|1|
L01EX03|PAZOPANIB|LH630|Pazopanib Teva|TABLETS FILM COATED|400 mg|mg|60|24000|Teva B.V, |1352.44|4|0|0|C|3|3||0|0.054|58386|1|
L01XG01|BORTEZOMIB|LH634|Bortezomib Accord|SOLUTION FOR INJECTION|2.5 mg/ml - 1.4 ml|mg|1|3.5|Accord Healthcare S.L.U., |150|1|4|0|C||3||1|42.84754|46380|1|
L01XK04|TALAZOPARIB|LH635|Talzenna|CAPSULE, HARD|0.25 mg|mg|30|7.5|Pfizer Europe MA EEIG, |2037.94|4|0|0|C|3|3||0|271.63804|54552|1|
L01XK04|TALAZOPARIB|LH636|Talzenna|CAPSULE, HARD|1 mg|mg|30|30|Pfizer Europe MA EEIG, |8151.76|4|0|0|C|3|3||0|271.63804|54556|1|
L02BX03|ABIRATERONE ACETATE|LH639|Abiraterone Pharmascience|FILM-COATED TABLET|500 mg|mg|60|30000|Pharmascience International Ltd., |543.6|4|0|0|C|3|2||0|0.01812|58457|1|
L02BX03|ABIRATERONE ACETATE|LH645|Abiraterone Accord|TABLETS FILM COATED|500 mg|mg|60|30000|Accord Healthcare S.L.U., |543.6|4|0|0|C|3|2||0|0.01812|45181|1|
L01EM03|ALPELISIB|LH646|Piqray|FILM-COATED TABLET|200 mg|mg|28|5600|Novartis Europharm Ltd., |4146.35|4|0|0|C|3|3||0|0.77538|17372|1|
L01EM03|ALPELISIB|LH647|Piqray|FILM-COATED TABLET|150 mg|mg|56|8400|Novartis Europharm Ltd., |6218.42|4|0|0|C|3|3||0|0.77538|17409|1|
L01EM03|ALPELISIB|LH648|Piqray|FILM-COATED TABLET|50 mg + 200 mg|mg|56|7000|Novartis Europharm Ltd., |5181.28|4|0|0|C|3|3||0|0.77538|17371|1|
L01EX02|SORAFENIB|LH649|Sorafenib Teva|FILM-COATED TABLET|200 mg|MG|112|22400|Teva B.V, |1385.56|4|0|0|C|3|3||0|0.0618|43962|1|
L01FD01|TRASTUZUMAB|LH650|Zercepac|CONCENTRATE FOR SOLUTION FOR INFUSION|150 mg|MG|1|150|Accord Healthcare S.L.U., |271.72|1|4|0|C||3||1|2.48744|55901|1|
L01EA02|DASATINIB|LH651|Dasatinib Zentiva|FILM-COATED TABLET|50 mg|MG|60|3000|Zentiva k.s.,  |1885.98|4|0|0|C|3|3||0|0.624|30499|1|
L01EA02|DASATINIB|LH652|Dasatinib Teva|FILM-COATED TABLET|50 mg|MG|30|1500|Teva B.V, |942.99|4|0|0|C|3|3||0|0.624|31001|1|
L02BX03|ABIRATERONE ACETATE|LH653|Abiraterone STADA|FILM-COATED TABLET|500 mg|mg|60|30000|Stada Arzneimittel AG, |543.6|4|0|0|C|3|2||0|0.01812|58479|1|
L01FC02|ISATUXIMAB|LH654|Sarclisa|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 5 ml|mg|1|100|Sanofi Winthrop Industrie, |992.59|1|4|0|C||4||1|10.66788|53896|1|
L01FC02|ISATUXIMAB|LH655|Sarclisa|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 25 ml|mg|1|500|Sanofi Winthrop Industrie, |4962.96|1|4|0|C||4||1|10.66788|53898|1|
L01EX14|ENTRECTINIB|LH656|Rozlytrek|CAPSULE, HARD|100 mg|mg|30|3000|Roche Registration GmbH, |1662.12|4|0|0|C|3|3||0|0.55806|53838|1|
L02BX03|ABIRATERONE ACETATE|LH657|Abiraterone Teva|TABLETS FILM COATED|500 mg|mg|60|30000|Teva B.V, |543.6|4|0|0|C|3|2||0|0.01812|59205|1|
L01EH03|TUCATINIB|LH658|Tukysa|TABLETS FILM COATED|50 mg|mg|88|4400|Pfizer Europe MA EEIG, |3259.28|4|0|0|C|3|3||0|0.74084|55072|1|
L01EH03|TUCATINIB|LH659|Tukysa|TABLETS FILM COATED|150 mg|mg|84|12600|Pfizer Europe MA EEIG, |9337.64|4|0|0|C|3|3||0|0.74084|55073|1|
L01FD04|TRASTUZUMAB DERUXTECAN|LH661|Enhertu|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|100 mg|mg|1|100|Daiichi Sankyo Europe GmbH, |3291.77|1|2|0|C||3||1|36.372|47859|1|
L01XX73|SOTORASIB|LH662|Lumykras|TABLETS FILM COATED|120 mg|mg|240|28800|Amgen Eurpe B.V., |9132.73|4|0|0|C|3|3||0|0.31695|57357|1|
L01XY01|DAUNORUBICIN,CYTARABINE|LH663|Vyxeos liposomal|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|44 mg/100 mg|mg|1|144|Jazz Pharmaceuticals Ireland Limited, |11026.45|1|3|0|C|6|1||1|76.5658|55603|1|
L01AA09|BENDAMUSTINE HYDROCHLORIDE|LH664|Bendamustine Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 4ml|mg|5|500|Accord Healthcare Polska , |387.52|1|4|0|C|6|1||1|0.81458|58806|1|
L01BC07|AZACITIDINE|LH665|Azacitidine STADA|POWDER FOR SUSPENSION FOR INJECTION|25 mg/ml (1 vial x 150 mg)|MG|1|150|Stada Arzneimittel AG, |205.82|3|1|0|C||1||1|1.7815|59491|1|
L01FD01|TRASTUZUMAB|LH666|Herzuma|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|150 mg|mg|1|150|Celltrion Healthcare Hungary Kft., |271.72|1|4|0|C||3||1|2.48744|16309|1|
L01EA02|DASATINIB|LH667|Dasatinib Sandoz|FILM-COATED TABLET|50 mg|mg|60|3000|Sandoz d.d., |1885.98|4|0|0|C|3|3||0|0.624|30358|1|
L01FA01|RITUXIMAB|LH668|Ruxience|CONCENTRATE FOR SOLUTION FOR INFUSION|10 MG/ML - 10 ML|mg|1|100|Pfizer Europe MA EEIG, |122.27|1|4|0|C||3||1|1.22243|53844|1|
L01FA01|RITUXIMAB|LH669|Ruxience|CONCENTRATE FOR SOLUTION FOR INFUSION|500 mg (10 mg/ml-50 ml)|mg|1|500|Pfizer Europe MA EEIG, |611.35|1|4|0|C||3||1|1.22243|53845|1|
L01FG01|BEVACIZUMAB|LH670|VEGZELMA|CONCENTRATE FOR SOLUTION FOR INFUSION|25mg/ml - 16ml|mg|1|400|Celltrion Healthcare Hungary Kft., |614.54|1|4|0|C|8|3||1|2.34747|59910|1|
L01FG01|BEVACIZUMAB|LH671|VEGZELMA|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 4ml|mg|1|100|Celltrion Healthcare Hungary Kft., |156.33|1|4|0|C|8|3||1|2.34747|59909|1|
L01EL02|ACALABRUTINIB|LH672|Calquence|TABLETS FILM COATED|100 mg|mg|56|5600|Astra Zeneca AB, |13300.08|4|0|0|C|3|3||0|2.375|60986|1|
L01CD04|CABAZITAXEL|LH673|Cabazitaxel Sandoz|CONCENTRATE FOR SOLUTION FOR INFUSION|10 mg/ml - 6 ml|mg|1|60|Sandoz Pharmaceuticals d.d., |1414.99|1|2|0|C|7|1||1|23.57121|26897|1|
L02BA03|FULVESTRANT|LH674|Fulvestrant Teva|SOLUTION FOR INJECTION|250 mg/5 ml|mg|2|500|Teva B.V, |279.78|2|1|0|C|8|2||0|0.58344|17225|1|
L01BC07|AZACITIDINE|LH675|Onureg|TABLETS FILM COATED|300 mg|MG|7|2100|Bristol-Myers Squibb Pharma EEIG, |15065.03|4|0|0|C|3|1||0|7.21024|51973|1|
L01EA06|ASCIMINIB|LH676|Scemblix|TABLETS FILM COATED|20 mg|MG|60|1200|Novartis Europharm Ltd., |4718.24|4|0|0|C|3|3||0|3.93099|60790|1|
L01EA06|ASCIMINIB|LH677|Scemblix|TABLETS FILM COATED|40 mg|MG|60|2400|Novartis Europharm Ltd., |9436.48|4|0|0|C|3|3||0|3.93099|60792|1|
L01EJ02|FEDRATINIB|LH678|Inrebic|CAPSULE, HARD|100 mg|MG|120|12000|Bristol-Myers Squibb Pharma EEIG, |7198.2|4|0|0|C|3|3||0|0.61412|49301|1|
L01EL03|ZANUBRUTINIB|LH679|Brukinsa|CAPSULE, HARD|80 mg|MG|120|9600|BeOne Medicines Ireland Ltd., |10627.46|4|0|0|C|3|3||0|1.10688|46483|1|
L01EN02|PEMIGATINIB|LH680|Pemazyre|TABLET|4.5 mg|MG|14|63|Incyte Biosciences Distribution B.V., |14529.58|4|0|0|C|3|3||0|230.55299|52144|1|
L01EX08|LENVATINIB|LH681|Lenvima|CAPSULE, HARD|10 mg|mg|30|300|Eisai GmbH, |2971.39|4|0|0|C|3|3||0|10.42221|50472|1|
L01EX08|LENVATINIB|LH682|Lenvima|CAPSULE, HARD|4 mg|mg|30|120|Eisai GmbH, |1188.56|4|0|0|C|3|3||0|10.42221|17079|1|
L01FX12|TAFASITAMAB|LH685|Minjuvi|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|200 mg|MG|1|200|Incyte Biosciences Distribution B.V., |1508.96|1|4|0|C||3||1|7.53741|51118|1|
L01FX13|ENFORTUMAB VEDOTIN|LH686|Padcev|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg|MG|1|20|Astellas Pharma Europe B.V., |1025.31|1|4|0|C||3||1|51.24004|58828|1|
L01FX13|ENFORTUMAB VEDOTIN|LH687|Padcev|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|30 mg|MG|1|30|Astellas Pharma Europe B.V., |1537.97|1|4|0|C||3||1|51.24004|58829|1|
L01FX17|SACITUZUMAB GOVITECAN|LH688|Trodelvy|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|200 mg|MG|1|200|Gilead Sciences Ireland UC, |2144.51|1|4|0|C||3||1|11.10162|55048|1|
L01FX18|AMIVANTAMAB|LH689|Rybrevant|CONCENTRATE FOR SOLUTION FOR INFUSION|350 mg|MG|1|350|Janssen-Cilag International N.V., |2791.1|1|4|0|C||3||0|7.97457|57352|1|
L01XX75|TEBENTAFUSP|LH690|Kimmtrak|CONCENTRATE FOR SOLUTION FOR INFUSION|100 mcg/0.5 ml|MCG|1|100|Immunocore Ireland Limited, |23247.34|1|4|0|C||3||0|232.5804|58739|1|
L02BA03|FULVESTRANT|LH691|Faslodex|SOLUTION FOR INJECTION|250 mg/5 ml|mg|2|500|Astra Zeneca AB, |279.78|2|1|0|C|8|2||0|0.58344|2765|1|
L02BA03|FULVESTRANT|LH692|Imarsa|SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE|250 mg/5 ml|MG|2|500|Gedeon Richter Plc., |279.78|2|1|0|C|8|2||0|0.58344|17491|1|
L02BA03|FULVESTRANT|LH693|Vastaloma|SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE|250 mg/5 ml|mg|2|500|Zentiva k.s.,  |279.78|2|1|0|C|8|2||0|0.58344|17459|1|
L03AA13|PEGFILGRASTIM|LH697|Nyvepria|SOLUTION FOR INJECTION|6mg/0.6ml|mg|1|6|Pfizer Europe MA EEIG, |560.62|3|1|0|C|7|5||0|93.38995|51643|0|
L02BA03|FULVESTRANT|LH698|Fulvestrant Pharmascience|SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE|250 mg/5 ml|mg|2|500|Pharmascience International Ltd., |279.78|2|1|0|C|8|2||0|0.58344|17217|1|
L01EA02|DASATINIB|LH699|Dasatinib Teva|FILM-COATED TABLET|50 mg|MG|30|1500|Teva B.V, |949|4|0|0|C|3|3||0|0.624|31001|1|
L01AA01|Cyclophosphamide|LH701|Cyclophosphamide Sandoz|CONCENTRATE FOR SOL. FOR INJECTION/INFUSION|100 mg/ml - 5 ml|mg|1|500|Sandoz d.d., |20.3|1|4|0|C|7|1||1|0.03479|64322|1|
L02BA03|FULVESTRANT|LH702|Fulvestrant Sandoz|SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE|250 mg/5 ml|mg|2|500|Sandoz d.d., |279.78|2|1|0|C|8|2||0|0.58344|17202|1|
L01FF05|ATEZOLIZUMAB|LH703|Tecentriq|SOLUTION FOR INJECTION|125 mg/ml - 15 ml|mg|1|1875|Roche Registration GmbH, |7741.81|3|1|0|C||4||0|4.12553|63590|1|
L01BC06|CAPECITABINE|LH704|Capecitacon|TABLETS FILM COATED|500 mg|mg|120|60000| , |112.01|4|0|0|C|3|1||0|0.00187|64295|1|
L01FG01|BEVACIZUMAB|LH705|Abevmy|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 4ml|mg|1|100|Biosimilar Collaborations Ireland Limited, |156.33|1|3|0|C|8|3||1|2.34747|45137|1|
L01FG01|BEVACIZUMAB|LH706|Abevmy|CONCENTRATE FOR SOLUTION FOR INFUSION|25mg/ml - 16ml|mg|1|400|Biosimilar Collaborations Ireland Limited, |614.54|1|3|0|C|8|3||1|2.34747|45139|1|
L01EA04|BOSUTINIB|LH707|Bosutinib Zentiva|TABLETS FILM COATED|100 mg|mg|28|2800|Zentiva k.s.,  |465.37|4|0|0|C|3|3||0|0.1662|64575|1|
L01BC07|AZACITIDINE|LH708|Azacitidine Accord|POWDER FOR SUSPENSION FOR INJECTION|25 mg/ml (1 vial x 150 mg)|mg|1|150|Accord Healthcare S.L.U., |205.82|3|1|0|C||1||1|1.7815|58095|1|
L01EA03|NILOTINIB|LH710|Nilotinib Pharmascience|CAPSULE, HARD|150 mg|MG|28|4200|Pharmascience International Ltd., |448.96|4|0|0|C|3|3||0|0.1068|65539|1|
L01EA03|NILOTINIB|LH711|Nilotinib Pharmascience|CAPSULE, HARD|200 mg|MG|28|5600|Pharmascience International Ltd., |598.4|4|0|0|C|3|3||0|0.1068|65549|1|
L01CD01|PACLITAXEL|LH712|Apexelsin|POWDER FOR DISPERSION FOR INFUSION|5mg/ml (100mg)|mg|1|100|Whiteoak Pharmaceutical B.V., |270.36|1|3|0|C||1||1|2.70225|65663|1|
L01EA03|NILOTINIB|LH713|Nilotinib Zentiva|CAPSULE, HARD|150 mg|mg|112|16800|Zentiva k.s.,  |1795.85|4|0|0|C|3|3||0|0.1068|65709|1|
L01EA03|NILOTINIB|LH714|Nilotinib Zentiva|CAPSULE, HARD|200 mg|mg|112|22400|Zentiva k.s.,  |2394.25|4|0|0|C|3|3||0|0.1068|65703|1|
L01FX25|MOSUNETUZUMAB|LH715|Lunsumio|CONCENTRATE FOR SOLUTION FOR INFUSION|1 mg/ml - 1 ml|mg|1|1|Roche Registration GmbH, |491.49|1|4|0|C||3||0|490.94969|59186|1|
L01FX25|MOSUNETUZUMAB|LH716|Lunsumio|CONCENTRATE FOR SOLUTION FOR INFUSION|1 mg/ml - 30 ml|mg|1|30|Roche Registration GmbH, |14744.57|1|4|0|C||3||0|490.94969|59187|1|
L01FX20|TREMELIMUMAB|LH717|Imjudo|CONCENTRATE FOR SOLUTION FOR INFUSION|300 mg/15 ml (20 mg/ml)|mg|1|300|Astra Zeneca AB, |28175.95|1|2|0|C||3||1|93.91957|62598|1|
L01EX19|RIPRETINIB|LH718|Qinlock|TABLET|50 mg|mg|90|4500|Deciphera Pharmaceuticals (Netherlands) B.V., |43053.65|4|0|0|C||3||0|9.56747|53011|1|
L01FX24|TECLISTAMAB|LH719|Tecvayli|SOLUTION FOR INJECTION|10 mg/ ml - 3 ml|mg|1|30|Janssen-Cilag International N.V., |1948.03|3|4|0|C||3||1|68.2232|62627|1|
L01FX24|TECLISTAMAB|LH720|Tecvayli|SOLUTION FOR INJECTION|90 mg/ml - 1.7 ml|mg|1|153|Janssen-Cilag International N.V., |9934.96|3|4|0|C||3||1|68.2232|62628|1|
L01FX27|EPCORITAMAB|LH721|Tepkinly|SOLUTION FOR INJECTION|48 mg (60 mg/ml - 0.8 ml)|mg|1|48|AbbVie Deutschland GmbH & Co. KG, |13343.29|3|4|0|C||3||0|275.37682|63750|1|
L01FX28|GLOFITAMAB|LH722|Columvi|CONCENTRATE FOR SOLUTION FOR INFUSION|10 mg/10 mg|mg|1|10|Roche Registration GmbH, |7275.95|1|4|0|C||3||0|726.299|64344|1|
L01FX28|GLOFITAMAB|LH723|Columvi|CONCENTRATE FOR SOLUTION FOR INFUSION|2.5 mg/2.5 ml (1 mg/ml)|mg|1|2.5|Roche Registration GmbH, |1818.99|1|4|0|C||3||0|726.299|64339|1|
L01FX32|ELRANATAMAB|LH724|Elrexfio|SOLUTION FOR INJECTION|40 mg/ml - 1.9 ml|mg|1|76|Pfizer Europe MA EEIG, |11822.09|3|4|0|C||3||0|154.83458|63678|1|
L01FX32|ELRANATAMAB|LH725|Elrexfio|SOLUTION FOR INJECTION|40 mg/ml - 1.1 ml|mg|1|44|Pfizer Europe MA EEIG, |6844.37|3|4|0|C||3||1|154.83458|63676|1|
L01FY02|NIVOLUMAB,RELATLIMAB|LH726|Opdualag|CONCENTRATE FOR SOLUTION FOR INFUSION|240 mg/80 mg|mg|1|320|Bristol-Myers Squibb Pharma EEIG, |8567.32|1|1|0|C||3||0|42.23631|62603|1|
L01XK52|NIRAPARIB, ABIRATERONE|LH727|Akeega|TABLETS FILM COATED|50 mg/500 mg|mg|56|30800|Janssen-Cilag International N.V., |10808.18|4|0|0|C||8||0||63591|1|
L01XK52|NIRAPARIB, ABIRATERONE|LH728|Akeega|TABLETS FILM COATED|100 mg/500 mg|mg|56|33600|Janssen-Cilag International N.V., |10808.18|4|0|0|C||8||0||63592|1|
L01XX62|IVOSIDENIB|LH729|Tibsovo|TABLETS FILM COATED|250 mg|mg|60|15000|Les Laboratoires Servier, |23481.96|4|0|0|C||3||0||61686|1|
L01XX62|IVOSIDENIB|LH730|Tibsovo|TABLETS FILM COATED|250 mg|mg|60|15000|Les Laboratoires Servier, |23481.96|4|0|0|C||3||0|1.56546|61686|1|
L01CD04|CABAZITAXEL|LH731|Cabazitaxel EVER Pharma|CONCENTRATE FOR SOLUTION FOR INFUSION|10 mg/ml - 6 ml|mg|1|60|Ever Valinject GmbH, |1414.99|1|2|0|C|7|1||1|23.57121|57732|1|
L01XX41|ERIBULIN|LH732|Eribulin EVER Pharma|SOLUTION FOR INJECTION|0.44mg/ml - 1 vial x 2ml|mg|1|0.88|Ever Valinject GmbH, |257.46|1|4|0|C||1||1|292.37613|65443|1|
L01XG01|BORTEZOMIB|LH733|Bortezomib EVER Pharma|SOLUTION FOR INJECTION|2.5 mg/ml - 1.4 ml|mg|1|3.5|Ever Valinject GmbH, |150|1|4|0|C||3||1|42.84754|60889|1|
L01XX41|ERIBULIN|LH734|Eribulin STADA|SOLUTION FOR INJECTION|0.44mg/ml - 1 vial x 2ml|mg|1|0.88|Stada Arzneimittel AG, |257.46|1|4|0|C||1||1|292.37613|64842|1|
L04AX06|POMALIDOMIDE|LH735|Pomalidomide Zentiva|CAPSULE, HARD|4 mg|mg|21|84|Zentiva k.s.,  |3861.38|4|0|0|C|3|1||0|45.94618|65622|1|
L02BA03|FULVESTRANT|LH736|Fulvestrant VER Pharma|SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE|250 mg/5 ml|mg|2|500|Ever Valinject GmbH, |279.78|2|1|0|C|8|2||0|0.58344|17525|1|
L01EA03|NILOTINIB|LH737|Nilotinib Accord|CAPSULE, HARD|150 mg|mg|112|16800|Accord Healthcare S.L.U., |1795.85|4|0|0|C|3|3||0|0.1068|65990|1|
L01BC06|CAPECITABINE|LH738|Capecitabine Zentiva|FILM-COATED TABLET|500|mg|120|60000|Zentiva k.s.,  |112.01|4|0|0|C|3|1||0|0.00187|66091|1|
L01EA03|NILOTINIB|LH739|Nilotinib Stada|CAPSULE, HARD|150 mg|mg|28|4200|Stada Arzneimittel AG, |448.96|4|0|0|C|3|3||0|0.1068|65911|1|
L01EA03|NILOTINIB|LH740|Nilotinib Stada|CAPSULE, HARD|200 mg|mg|28|5600|Stada Arzneimittel AG, |598.4|4|0|0|C|3|3||0|0.1068|65943|1|
L04AX06|POMALIDOMIDE|LH741|Pomalidomide Grindeks|CAPSULE, HARD|4 mg|mg|21|84|AS Grindeks, |3861.38|4|0|0|C|3|1||0|45.94618|66489|1|
L01EK01|AXITINIB|LH742|Axitinib Accord|TABLETS FILM COATED|5 mg|mg|56|280|Accord Healthcare S.L.U., |2376.31|4|0|0|C|3|3||0|19.14743|66205|1|
L01AA01|Cyclophosphamide|LH743|Cyclophosphacon|POWDER FOR SOLUTION FOR INJECTION|500 mg|mg|1|500| , |20.3|1|4|0|C|7|1||1|0.03479|66633|1|
L01BC07|AZACITIDINE|LH744|Azaciticon|POWDER FOR SUSPENSION FOR INJECTION|25 mg/ml (1 vial x 100 mg)|mg|1|100| , |137.21|3|1|0|C||1||1|1.7815|66216|1|
L01EK01|AXITINIB|LH745|Axitinib Sandoz|TABLETS FILM COATED|5 mg|mg|60|300|Sandoz d.d., |2546.05|4|0|0|C|3|3||0|19.14743|61180|1|
L01EK01|AXITINIB|LH746|Axitinib Sandoz|TABLETS FILM COATED|1 mg|mg|60|60|Sandoz d.d., |509.21|4|0|0|C|3|3||0|19.14743|61175|1|
L04AX06|POMALIDOMIDE|LH747|Pomalidomide Accord|CAPSULE, HARD|4 mg|mg|21|84|Accord Healthcare S.L.U., |3861.38|4|0|0|C|3|1||0|45.94618|65651|1|
L01XX75|TEBENTAFUSP|LH748|Kimmtrak|CONCENTRATE FOR SOLUTION FOR INFUSION|100 mcg/0.5 ml|mcg|1|100|Immunocore Ireland Limited, |23247.34|1|4|0|C||3||0|232.5804|58739|1|
L01EK01|AXITINIB|LH749|Axitinib Teva|TABLETS FILM COATED|1 mg|mg|56|56|  , |475.26|4|0|0|C|3|3||0|19.14743|65251|1|
L01EK01|AXITINIB|LH750|Axitinib Teva|TABLETS FILM COATED|5 mg|mg|56|280|  , |2376.31|4|0|0|C|3|3||0|19.14743|65255|1|
L02BA03|FULVESTRANT|LH751|Fulvestrant Rompharm|SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE|250 mg/5 ml|mg|2|500|S.C.Rompharm Company S.R.L., |279.78|2|1|0|C|8|2||0|0.58344|26448|1|
L01CD04|CABAZITAXEL|LH753|Cabazitaxel EVER Pharma|CONCENTRATE FOR SOLUTION FOR INFUSION|10 mg/ml - 4.5 ml|mg|1|45|Ever Valinject GmbH, |1061.24|1|2|0|C|7|1||1|23.57121|57730|1|
L03AA13|PEGFILGRASTIM|LH754|Fulphila|SOLUTION FOR INJECTION|6 mg|mg|1|6|Biosimilar Collaborations Ireland Limited, |560.62|3|1|0|C|7|5||0|93.38995|48516|0|
M05BX04|Denosumab|MH017|Xgeva|sol. for inj.|120 mg/1.7ml|mg|1|120|Amgen Europe B.V., |326.05|3|1|0|C|8|6||0|4.4532|1470|1|
M05BA08|ZOLEDRONIC ACID|MH022|Zolendronic acid Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|4 MG/5 ML|mg|1|4|Accord Healthcare S.L.U., |22.91|1|4|0|C||6||0|5.7275|2866|1|
M05BA08|ZOLEDRONIC ACID|MH026|Zomtu|CONCENTRATE FOR SOLUTION FOR INFUSION|4 MG/5 ML|mg|1|4|   , |22.91|1|4|0|C||6||0|5.7275|43783|1|
M05BX04|DENOSUMAB|MH027|Osenvelt|SOLUTION FOR INJECTION|120 mg (70 mg/ml - 1.7 ml)|mg|1|120|Celltrion Healthcare Hungary Kft., |326.05|3|1|0|C|8|6||0|4.4532|67619|1|
M05BX04|DENOSUMAB|MH028|Wyost|SOLUTION FOR INJECTION|120 mg (70 mg/ml - 1.7 ml)|mg|1|120|Sandoz GmbH, |326.05|3|1|0|C|8|6||0|4.4532|66794|1|
M05BX04|DENOSUMAB|MH029|Yaxwer|SOLUTION FOR INJECTION|120 mg (70 mg/ml - 1.7 ml)|mg|1|120|Gedeon Richter Plc., |326.05|3|1|0|C|8|6||0|4.4532|68601|1|
N02AB02|Pethidine hydrochloride|NO588|LYDOL sol.for inj. 50 mg/ml- 2 ml x 10|solution for injection|50mg/ml-2ml|mg|10|1000| , |17.16|2|0|1|C||||0|0.01716|189|0|
N02AB03|FENTANYL|NO590|Victanyl|TRANSDERMAL PATCHES|75 mcg/h|mcg|5|375|Teva B.V, |35.42|4|0|1|C||||0|0.0936|2767|0|
N02AB03|FENTANYL|NO592|Victanyl|TRANSDERMAL PATCHES|50 mcg/h|mcg|5|250|Teva B.V, |23.62|4|0|1|C||||0|0.0936|1662|0|
N02AB03|FENTANYL|NO593|Victanyl|TRANSDERMAL PATCHES|100 mch/h|mcg|5|500|Teva B.V, |47.23|4|0|1|C||||0|0.0936|1663|0|
N02AA01|Morphine|NO597|MORPHINE SOPHARMA sol. inj. 20 mg/ml - 1 ml x 10|sol. inj.|20mg/ml-1ml|mg|10|200| , |14.76|2|0|1|C||||0|0.07376|142|0|
N02AA05|OXYCODONE|NO600|Oxycodone Actavis|CAPSULE, HARD|10 mg|mg|50|500|Teva B.V, |8.35|4|0|1|C||||0|0.01668|1809|0|
N02AA05|OXYCODONE|NO601|Oxycodone Actavis|CAPSULE, HARD|20 mg|mg|50|1000|Teva B.V, |16.69|4|0|1|C||||0|0.01668|1808|0|
N02AE01|BUPRENORPHINE|NO604|Buprenorphin Actavis|TRANSDERMAL PATCH|35 mcg/h|mcg|5|175|Teva B.V, |25.23|4|0|1|C||||0|0.14412|3508|0|
N02AE01|BUPRENORPHINE|NO605|Buprenorphin Actavis|TRANSDERMAL PATCH|52,5 mcg/h|mcg|5|262.5|Teva B.V, |37.85|4|0|1|C||||0|0.14412|2981|0|
N02AE01|BUPRENORPHINE|NO606|Buprenorphin Actavis|TRANSDERMAL PATCH|70 mcg/h|mcg|5|350|Teva B.V, |50.47|4|0|1|C||||0|0.14412|2187|0|
N02AA05|OXYCODONE|NO612|Oxycodone Actavis|TABL. RELEASE PROLONG|10 mg|mg|50|500|Teva B.V, |8.35|4|0|1|C||||0|0.01668|3053|0|
N02AA05|OXYCODONE|NO613|Oxycodone Actavis|TABL. RELEASE PROLONG|20 mg|mg|50|1000|Teva B.V, |16.69|4|0|1|C||||0|0.01668|3054|0|
N02AA05|OXYCODONE|NO614|Oxycodone Actavis|TABL. RELEASE PROLONG|40 mg|mg|50|2000|Teva B.V, |33.4|4|0|1|C||||0|0.01668|3055|0|
N02AA05|OXYCODONE|NO617|OXYLAN|PROLONGED-RELEASE TABLET|20 mg|mg|50|1000|G.L. Pharma GmbH, |16.69|4|0|1|C||||0|0.01668|3422|0|
N02AA05|OXYCODONE|NO618|OXYLAN|PROLONGED-RELEASE TABLET|40 mg|mg|50|2000|G.L. Pharma GmbH, |33.4|4|0|1|C||||0|0.01668|3423|0|
N02AA05|OXYCODONE|NO619|OXYLAN|PROLONGED-RELEASE TABLET|80 mg|mg|50|4000|G.L. Pharma GmbH, |66.78|4|0|1|C||||0|0.01668|3424|0|
N02AB03|FENTANYL|NO621|Vellofent|TABLETS SUBLINGUAL|133 mcg|mcg|4|532|   , |21.05|4|0|1|C||||0|0.03942|3234|0|
N02AA55|OXYCODONE HYDROCHLORIDE/ NALOXONE HYDROCHLORIDE|NO627|Oxycodone/Naloxone Teva|TABL. RELEASE PROLONG|10mg/5mg|mg|50|500|Teva B.V, |26.77|4|0|1|C||||0|0.05335|16342|0|
N02AA55|OXYCODONE HYDROCHLORIDE/ NALOXONE HYDROCHLORIDE|NO628|Oxycodone/Naloxone Teva|TABL. RELEASE PROLONG|20mg/10mg|mg|50|1000|Teva B.V, |53.5|4|0|1|C||||0|0.05335|16343|0|
N02AB03|FENTANYL|NO633|Fentadolor|SUBLINGUAL TABLETS|100 mcg|mcg|10|1000|Sandoz d.d., |44.54|4|0|1|C||||0|0.04445|61915|0|
N02AB03|FENTANYL|NO634|Sublifen|SUBLINGUAL TABLETS|100 mcg|mcg|10|1000|G.L. Pharma GmbH, |44.54|4|0|1|C||||0|0.04445|57729|0|
N02AB03|FENTANYL|NO635|PecFent|NASAL SPRAY, SOLUTION|100 g / spray - 1.55 ml (8 fu|mcg|4|3200|Kyowa Kirin Holdings B.V., |275.5|4|0|1|C||||0|0.08609|52129|0|
N02AA08|DIHYDROCODEINE|NP414|DHC Continus|MODIFIED RELEASE TABL.|90 mg|mg|50|4500|Ennogen Healthcare (Europe) Ltd, |26.22|4|0|1|C||||0|0.00583|3617|0|
N02AX02|TRAMADOL|NP415|Tramalgin|SOLUTION FOR INJECTION|50 mg/ml - 2 ml|mg|10|1000| , |9.76|2|0|1|C||||0|0.00976|148|0|
N02AX02|TRAMADOL|NP419|Tramadol Stada|CAPSULES|50 mg|mg|30|1500|Stada Arzneimittel AG, |5.75|4|0|1|C||||0|0.00383|1583|0|
N02AX02|TRAMADOL|NP420|Tramalgin|CAPSULES|50 mg|mg|20|1000| , |3.83|4|0|1|C||||0|0.00383|800|0|
V03AC01|DEFEROXAMINE|VH009|DESFERAL|POWDER FOR SOLUTION FOR INFUSION|500 mg|mg|10|5000|Novartis Europharm Ltd., |49.82|1|4|0|C|1|||0|0.00996|2774|0|
V03AF03|CALCIUM FOLINATE|VH015|Bendafolin|SOL.FOR INJ|10mg/ml-100ml|mg|1|1000|Lyomark Pharma GmbH, Germany|120.18|1|0|0|C|0|1||1|0.12|2573|1|
V03AF03|CALCIUM FOLINATE|VH016|Bendafolin|SOL.FOR INJ|10mg/ml-50ml|mg|1|500|Lyomark Pharma GmbH, Germany|60.06|1|0|0|C|0|1||1|0.12|2574|1|
V03AF03|CALCIUM FOLINATE|VH018|Calcium folinate Sandoz|SOLUTION FOR INJECTION/INFUSION|10 MG/ML - 10 ML|mg|1|100|Sandoz d.d., |12.04|1|0|0|C|0|1||1|0.12|15598|1|
V03AF03|CALCIUM FOLINATE|VH019|Calcium folinate Sandoz|SOLUTION FOR INJECTION/INFUSION|10 mg/ml - 5 ml|mg|5|250|Sandoz d.d., |30.06|1|0|0|C|0|1||1|0.12|15618|1|
V03AC03|DEFERASIROX|VH020|Exjade|FILM-COATED TABLET|180 mg|mg|30|5400|Novartis Europharm Ltd., |57.71|4|0|0|C|3|||0|0.01068|16126|0|
V03AF01|Mesna|VH021|UROMITEXAN|SOLUTION FOR INJECTION|100 mg/ml - 4 ml|mg|15|6000|  , |149.54|1|4|0|C|10|1||1|0.02404|4081|1|
V03AC03|DEFERASIROX|VH023|Deferasirox Mylan|TABLETS FILM COATED|180 mg|mg|30|5400|Mylan Pharmaceuticals Limited, |57.71|4|0|0|C|3|||0|0.01068|47338|0|
V03AC03|DEFERASIROX|VH024|Deferasirox Pharmascience|FILM-COATED TABLET|180 mg|MG|30|5400|Pharmascience International Ltd., |57.71|4|0|0|C|3|||0|0.01068|27728|0|
V03AC03|DEFERASIROX|VH025|Deferasirox Teva|FILM-COATED TABLET|180 mg|MG|30|5400|  , |57.71|4|0|0|C|3|||0|0.01068|32132|0|
V03AC03|DEFERASIROX|VH026|Zeoks|FILM-COATED TABLET|180 mg|mg|30|5400|Zentiva k.s.,  |57.71|4|0|0|C|3|||0|0.01068|31908|0|
V03AC03|DEFERASIROX|VH027|Ferupantil|TABLETS FILM COATED|180 mg|mg|30|5400|Sandoz Pharmaceuticals d.d., |57.71|4|0|0|C|3|||0|0.01068|32147|0|
V03AC03|DEFERASIROX|VH030|Deferasirox Accord|TABLETS FILM COATED|180 mg|mg|30|5400|Accord Healthcare S.L.U., |57.71|4|0|0|C|3|||0|0.01068|47326|0|
V03AC03|DEFERASIROX|VH032|Ziadex|TABLETS FILM COATED|360mg|mg|30|10800|  , |115.45|4|0|0|C|3|||0|0.01068|27078|0|
V03AC03|DEFERASIROX|VH033|Ziadex|TABLETS FILM COATED|180 mg|mg|30|5400|  , |57.71|4|0|0|C|3|||0|0.01068|27077|0|
V03AC03|DEFERASIROX|VH034|Deferasirox Pharmascience|DISPERSIBLE TABLET|250 mg|mg|28|7000|Pharmascience International Ltd., |53.45|4|0|0|C|3|||0|0.00763|28962|0|
V03AF03|CALCIUM FOLINATE|VH035|Folinic acid Kalceks|SOLUTION FOR INJECTION/INFUSION|10 MG/ML - 10 ML|mg|10|1000|AS KALCEKS, |120.18|1|0|0|C|0|1||1|0.12|64693|1|
V03AF03|CALCIUM FOLINATE|VH036|Folinic acid Kalceks|SOLUTION FOR INJECTION/INFUSION|10mg/ml-50ml|mg|10|5000|AS KALCEKS, |600.77|1|0|0|C|0|1||1|0.12|64699|1|
V03AF03|CALCIUM FOLINATE|VH037|Folinic acid Kalceks|SOLUTION FOR INJECTION/INFUSION|10mg/ml-100ml|mg|10|10000|AS KALCEKS, |1201.62|1|0|0|C|0|1||1|0.12|64701|1|
